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ABSTRACT OF THE DISSERTATION
Development and Design of Transition Metal-Catalyzed Transformations in
Macrocyclizations and Carbon–Carbon Bond Formations
By
Jan Riedel
Doctor of Philosophy in Chemistry
University of California, Irvine, 2019
Professor Vy M. Dong, Chair
Cyclic peptides have been recognized for their potential to mimic protein-protein interac-
tions. Traditionally, cyclizations are carried out at high dilution to suppress competitive
intermolecular reactions, which makes these cyclizations economically ineﬃcient and hard to
perform at scale. We developed the use of dehydro amino acids as traceless turn-inducers to
enable macrocyclizations at high concentrations. We demonstrated our strategy in the total
synthesis of dichotomin E at cyclization concentrations as high as 0.1 M. In collaboration with
Prof. Rachel Martin, we studied the origin of the turn-inducing eﬀect by CD-spectroscopy,
NMR and molecular mechanics simulations.
Inspired by nature’s ability to take a common precursor like geranyl pyrophosphate and cy-
clize it into an array of natural products (e.g., sabinene, limonene, camphene, and pinene), we
expanded the cycloisomerization chemistry of 2-allyl-4-pentenal derivatives. We found that
cobalt is a competent catalyst in the synthesis of cyclobutanones over cyclopentanones. We
propose a Co(0) active catalyst. Building on this chemistry, we extended our methodology by
making bicyclic systems. From a symmetrical starting material we aﬀect a desymmetrization
and build trans-fused hydrindanones selectively.
Using DFT, we studied the mechanism of a rhodium catalyzed cycloisomerization to under-
xi
stand the structure-selectivity relationship between ligand and reaction outcome. A unprece-
dented induced-ﬁt mechanism has been found operable, and the insights of these studies led
to the design and synthesis of new ligands to access new pathways.
Simple unsaturated nitriles play an important role as ﬂavoring agents and precursors for ﬁne
chemicals and polymers. Traditional synthesis would involve the use of halides and toxic
cyanides. We developed a method that improves previous approaches by using a Cu(II)
catalyst and di-tert-butyl peroxide to generate alkyl radicals from alkylnitriles. We used
unactivated oleﬁns and simple alkylnitriles in a broad reaction scope through double sp3
C–H activation. Internal as well as terminal oleﬁns are competent coupling partners. We
hypothesize, that the high chemo- and regioselectivity comes from a directing group eﬀect
of the nitrile to the copper catalyst.
xii
Chapter 1
Dehydro Amino Acids as
Turn-Inducer in the Cyclization of
Peptides: Total Synthesis of
Dichotomin E∗
∗Reproduced in part with permission from Le, D. N.*; Riedel, J.*; Kozlyuk, N.; Martin, R. W.; Dong,
V. M. Org. Lett. 2017, 19, 114. Copyright 2017 American Chemical Society
1
1.1 Total Synthesis of Dichotomin E
1.1.1 Introduction
Naturally occurring cyclic peptides have inspired the invention of strategies1–5 for organic
synthesis and therapeutics for use as antibiotics6–8 and immunosuppressants.9 In comparison
with their linear counterparts, these cyclic structures show enhanced metabolic stability,10
conformational rigidity,11 and potential to mimic protein-protein interactions.12 While sig-
niﬁcant progress has been made in the construction of relatively large cyclic peptides, the
construction of smaller peptides (i.e., those containing ﬁve or fewer amino acids) remains a
challenge.13–17 In addition, cyclizing peptides at high concentrations on an industrial scale
is important, and thus, a turn-inducer is desirable to ensure an eﬃcient and economically
feasible process.18,19 Speciﬁc amino acids (e.g., proline, pseudoproline, D-amino acids, and
N-methylated amino acids) have been identiﬁed as turninducers that can be incorporated
into a linear precursor to facilitate macrocyclizations.20–22 Ring closing of small peptides
without such turn-inducers is plagued by competitive dimerization and epimerization.23,24
Toward a more general solution to this challenge, we propose the use of dehydroamino acids
as traceless turn-inducers.
Dehydroamino acids modulate backbone conformations and produce folded structures.25–28
The impact of dehydrophenylalanine on the conformation of small peptides has been studied
extensively over the past decade.29–33 For example, Singh has shown that dehydropheny-
lalanines can induce β-turns in a linear tetrapeptide on the basis of X-ray crystallography
studies (Figure 1a).34 The ability of dehydroamino acids to impart folded conformations has
yet to be exploited to achieve eﬃcient ring closings in order to gain access to various cyclic
peptides. We envisioned that this unsaturated moiety could serve as a versatile functional
handle for further elaboration in the late-stage preparation of natural product derivatives.35
Moreover, these unsaturated derivatives could serve as analogues in structure- activity rela-
2
tionship (SAR) studies or serve as potential epitope mimetics.36,37 Here we report the ﬁrst
use of dehydrophenylalanine as a traceless turn-inducer via its application in the synthesis
of dichotomin E (1).
1.1.2 Results and Discussion
Isolated from the chickweed plant, Stellaria dichotoma, 1 is a cyclic peptide containing ﬁve
amino acids with cell growth inhibitory activity against leukemia cells.38 Our retrosynthetic
analysis for construction of this small cyclic peptide is summarized in Figure 1.1. First, we
imagined that the natural product could be obtained from cyclic peptide 2, containing a
(Z)-dehydrophenylalanine,39 by catalytic hydrogenation. In contrast to the incorporation
of other turn-inducers, the dehydrophenylalanine can be easily unveiled to the L- or D-
amino acid. Next, we chose to disconnect the glycine-alanine peptide bond to reveal the
linear and unsaturated peptide 3. We chose this disconnection to help favor an eﬀective
macrocyclization by placing the dehydrophenylalanine at the i + 2 position, where it was
previously reported to induce a β-turn.40 A similar disconnection was used in the previous
synthesis of 1 by Tam.41 In general, macrocyclizations are more favorable using glycine
because it is a relatively unhindered nucleophile.42
With this retrosynthetic analysis in mind, we prepared unsaturated pentapeptide 3 as shown
in Figure 1.2. Boc-L-alanine (6) was coupled to DL-(β-OH)-Phe-OMe (7) to aﬀord the cor-
responding dipeptide in 76% yield. Treatment with Boc anhydride and tetramethylguanidine
aﬀorded unsaturated dipeptide 8 in 91% yield.43 Subjecting 8 to hydrolysis, peptide cou-
pling, and deprotection gave tripeptide 4 in 63% yield. 4 was then coupled to dipeptide 5
in 61% yield to aﬀord the corresponding pentapeptide. After hydrolysis and deprotection,
unsaturated pentapeptide 3 was obtained in 97% yield. For comparison, we also prepared
saturated linear peptide 12 in 64% yield using solid-phase peptide synthesis (SPPS) (see the
3
b) Retrosynthesis: Exploiting dehydrophenylalanine as a traceless turn-inducer
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Figure 1.1. Retrosynthetic Analysis
Supporting Information (SI)).
When saturated linear pentapeptide 12 was subjected to macrocyclization at 0.1 M, only
a 15% yield of 1 was obtained, with 1.5:1 selectivity for the desired monomer over the
cyclodimer (Table 1.1). In stark contrast, treatment of unsaturated pentapeptide 3 under
the same conditions resulted in the formation of cyclic pentapeptide 2 in 74% yield, and the
selectivity improved to 20:1 for the monomer versus the cyclodimer. Subsequently, cyclic
pentapeptide 2 was isolated in 81% yield with 39:1 selectivity for the desired monomer over
cyclodimer at 0.05 M. In comparison to Tam’s method, where a silver-ion-assisted orthogonal
cyclization at 0.001 M concentration aﬀorded the macrolactam in 87% yield, our approach
circumvents the need for high dilution by using 100 times less solvent in the macrocyclization.
Next, we prepared pentapeptide 13 bearing two dehydroamino acids (see the SI) and sub-
jected this linear precursor to ring closing. Under the same cyclization conditions at 0.1
M concentration, cyclic pentapeptide 14 was isolated in 84% yield with improved 26:1 se-
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Figure 1.2. Synthesis of Unsaturated Pentapeptide 3
lectivity for the monomer over the cyclodimer (cf. Table 1.1).∗ Together, these results
demonstrate that dehydrophenylalanines act as turn-inducers that greatly favor macrocy-
clization even at high concentrations. With unsaturated cyclic peptides 2 and 14 in hand,
we applied hydrogenation to install the ﬁnal stereocenters. Hydrogenation of cyclic peptide
2 using Rh(cod)2BF4 and the achiral dppp ligand resulted in the formation of an 8:1 mixture
favoring epimer 15 of dichotomin E (Figure 1.3).
NH
NHO
N
H
O Me
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MeO
HO Ph
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H
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O
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HO Ph
[Rh(cod)2BF4] 
(5 mol%)
dppp (5 mol%)
MeOH, 30 oC
 H2 (30 atm),
 36 h
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2 15
Figure 1.3. Hydrogenation Yielding Epimer of Dichotomin E
To overcome the inherent substrate bias, we turned to asymmetric hydrogenation, which
is commonly used in the synthesis of medicines in industry.44 Liu and Zhang45 previously
∗Additionally, when we switched the position of the dehydroamino acid to tyrosine, we saw predominant
dimer formation over monomer formation (see the SI)
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Table 1.1. Effect of Dehydroamino Acid on Macrocyclization
NH
NHO
N
H
O Me
O
HN
HN
O
MeO
HO
HATU (1.2 equiv) 
HOAt (1.2 equiv)
i-Pr2EtN (2.5 equiv)
 DMF, 0 °C →rt
NH
NHO
N
H
O Me
O
HN Ph
HN
O
MeO
HO
NHO
N
H
O Me
O
HN Ph
HN
O
MeO
HO
H2N HO
TFA•
NHO
N
H
O Me
O
HN Ph
HN
O
MeO
HO
H2N HO
Ph
HATU (1.2 equiv) 
HOAt (1.2 equiv)
i-Pr2EtN (2.5 equiv)
 DMF, 0 °C →rt
30 min, 0.1 M
30 min
NH
NHO
N
H
O Me
O
HN
HN
O
MeO
BnO
HATU (1.2 equiv) 
HOAt (1.2 equiv)
i-Pr2EtN (2.5 equiv)
 DMF, 0 °C →rtNHO
N
H
O Me
O
HN Ph
HN
O
MeO
BnO
H2N HO
TFA•
Ph
30 min, 0.1 M
a)
b)
c)
entry n*
selectivity** 
(monomer:dimer)
1
2
3
4
1.5:1
20:1
39:1
26:1
0
1
1
2
* n = number of dehydroamino acids
** determined by HPLC
*** isolated yield.
yield***
15%
74%
81%
84%
concentration
(mol/l)
0.1
0.1
0.05
0.1
12 1
3 2
13 14
reported the asymmetric hydrogenation of enamides using Rh(I) with Duanphos as the ligand
to aﬀord the corresponding amide with 99% ee. By using 5 mol% Rh(cod)2BF4 and 5 mol%
(S,S’,R,R’ )-Duanphos in THF under 30 atm hydrogen, we were able to hydrogenate peptide
2 and obtain dichotomin E (1) in 96% yield with >95:5 dr (Figure 1.4). It is worthy of note
that reduction of cyclic peptide 2 using (R,R’,S,S’ )- Duanphos aﬀords the epimer 15 in 82%
yield with >95:5 dr. Cyclic peptide 14 bearing two enamides can also be transformed to
dichotomin E by tandem asymmetric reduction followed by debenzylation (Figure 1.4).
To better understand the mechanism of macrocyclization, we performed CD-spectroscopy
experiments on pentapeptides 12, 3, and 2 in MeOH (298 K) to investigate the presence
of secondary structure (Figure 1.5).46 Uncyclized dehydropeptide 3 showed absorption pat-
terns consistent with a cyclized structure, similar to cyclic dehydropeptide 2. In contrast,
uncyclized, saturated pentapeptide 12 showed no absorption patterns indicative of any sec-
ondary structural motif. The CD spectrum supports the pronounced eﬀect of the presence
of dehydrophenylalanine on the secondary structure of uncyclized dehydropeptide 3, which
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: R = H, 96% yield, >20:1 dr
NH
NHO
N
H
O Me
O
HN Ph
HN
O
MeO
RO
NH
NHO
N
H
O Me
O
HN
HN
O
MeO
RO Ph
: R = H
: R = Bn
a For , MeOH was used. For , THF was used.
b
 Pd/C (20 mol%), H2, 28 h, 30o, 99% yield
P
P
H
t-Bu
H
t-Bu
: R = Bn, 90% yield, >20:1:1:1 dr
[Rh(cod)2BF4]
(5 mol%)
L* (5 mol%)
H2, 30 °C, 36 h
solventa
L*= (S,S',R,R')-
Duanphos
b214
1
16
2 14
Figure 1.4. Asymmetric Hydrogenation to Yield Dichotomin E
helps to facilitate macrocyclization.
Figure 1.5. CD spectra of pentapeptides 12, 3, and 2
We used solution-state NMR spectroscopy and molecular modeling to elucidate the struc-
ture of unsaturated pentapeptide 3. The 3J couplings for the Tyr residue and the two Ala
residues were obtained from 2D J-resolved 1H NMR spectra.47 These couplings were used to
calculate HNHα Φ dihedral angles via the Karplus relation.
48 Using these dihedral angle and
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2D NOESY restraints, we performed molecular modeling studies with Maestro∗ to obtain 20
low-energy conformations that were consistent with our experimental observations (see the
SI). These calculations support the lowest-energy structure 17 containing a left-handed α-
turn, which is preorganized toward macrocyclization (Figure 1.6). Intramolecular H-bonding
was also investigated using the temperature coeﬃcients of the N-H chemical shifts (Δδ/ΔT),
which can be used as an indicator of intramolecular H-bonding as opposed to H-bonds to
solvent.49,50 A value of -0.0039 ppm/K was obtained for the internal alanine N-H in dehy-
dropeptide 3, in contrast to the value of -0.0052 ppm/K observed for saturated pentapeptide
12 (see the SI). This diﬀerence suggests that there is dynamic intramolecular H-bonding in
dehydropeptide 3 but not in saturated pentapeptide 12, consistent with the ensemble of
structures predicted by the molecular modeling. Together, these results demonstrate that a
single dehydrophenylalanine residue can induce a left-handed α-turn.
NH
NH
HN
H
N
OH
OMeH2N
O
HO
O
Me
OH
H
O
H
TMP1
Figure 1.6. Minimized-energy conformation 17 of unsaturated peptide 3
When we replaced the phenyl substituent with a cyclohexyl substituent in 3, cyclic monomer
formation was observed in a promising yet less eﬃcient 54% yield by 1H NMR analysis (see
the SI). This result suggests that the steric impact of the substituent inﬂuences the cycliza-
tion. In view of the higher-yielding macrocyclizations we observed in Table 1.1, conjugation
between the phenyl substituent and the alkene helps promote ring closing by increasing the
steric impact of the phenyl group. Weiss, Lawrence, and co-workers used dehydrophenylala-
nine as a β- breaker to study insulin and showed that extended conjugation of the aromatic
π electrons with the neighboring C=C and C=O electrons enforces near-planarity.51 The
∗Schro¨dinger, release 2015-2: Maestro, version 10.2; Schro¨dinger, LLC: New York, 2015.
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near-planar conformation of dehydrophenylalanine results in a greater steric interaction be-
tween the phenyl group and the adjacent amide group, as shown in 17, which ultimately
restricts the Φ angle of the dehydroamino acid.33 This restriction, through the increased A1,3
strain, biases the N- and C-termini toward cyclization. Interestingly, a peptide containing
three consecutive dehydroalanine units has been shown to adopt an extended conformation
in which all of the amide groups show near-planarity.52 This example suggests that the steric
interactions of the group at the β- carbon of the dehydroamino acid are correlated to its
ability to induce a turn. In conclusion, we have demonstrated dehydrophenylalanine as an
eﬀective and traceless turn-inducer in the synthesis of dichotomin E. NMR analysis revealed
that unsaturated pentapeptide 3 adopts a cyclic, preorganized structure. The enamide serves
as a turn-inducer to facilitate ring closing without the need for high dilution. Moreover, it is
a convenient functional handle for the late-stage construction of natural products and their
derivatives. In SPPS, the overall yield is typically exceptional because each step in this linear
approach is driven by exploiting excess reagents.53 Combined with the need for dilute solvent
conditions, the amount of waste generated in this traditional approach to cyclic peptide con-
struction is signiﬁcant. Our approach aims for a more eﬃcient synthesis of cyclic peptides,
especially on a large scale, while SPPS enables the rapid synthesis of peptide libraries on
a small scale. Future studies in our laboratory will be focused on better understanding (1)
the scope and limitations of dehydroamino acids as turn-inducers for macrocyclization∗ and
(2) the mechanism of tandem hydrogenations in cyclic enamides. We expect that our simple
yet eﬀective strategy for ring closing will be of use to chemists interested in accessing cyclic
pentapeptides for use as biological probes and therapeutics.
∗Our method is currently limited to the synthesis of cyclic pentapeptides. When we cyclized the linear
tetrapeptide (HO-Ala-ΔPhe-Ala-Gly-NH2) at 0.01 M, we observed the formation of the cyclooctamer via
LC-MS analysis.
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1.2 Experimental Data
The details of the studies described in this chapter can be found in the Supporting Infor-
mation of the published manuscript.54 My contributions to the project are detailed in this
section.
1.2.1 Experimental Details
Representative peptide coupling with EDCI (Method A)
To a round bottom ﬂask equipped with a stir bar was added Boc-l-alanine (5.00 g, 26.4 mmol),
dl-(β-OH)–Phe–OMe (6.13 g, 26.4 mmol), HOBt·H2O (4.29 g, 31.7 mmol), and DCM
(100 mL). The mixture was cooled to 0 ◦C and Et3N (9.16 mL, 66.1 mmol) was subse-
quently added. EDCI·HCl (6.08 g, 31.7 mmol) was added in portions and the reaction
gradually warmed to rt and stirred for 22 h. The reaction mixture was transferred to a
separatory funnel and was washed with 100 mL sat. NaHCO3 (aq), 100 mL 10% KHSO4
(aq), and 100 mL brine. The organic phase was dried over Na2SO4, ﬁltered, and concen-
trated under reduced pressure. The unpuriﬁed reaction mixture was then puriﬁed by column
chromatography (eluting with 20:1 DCM/MeOH) to aﬀord the corresponding dipeptide as
a white solid (7.4 g, 76%).
Representative elimination to form dehydroamino acid (Method B)
The procedure was adapted from Sua´rez.∗ To a round bottom ﬂask equipped with a
stir bar was added methyl 2-((S )-2-((tert-butoxycarbonyl)amino)propanamido)-3-hydroxy-
3-phenylpropanoate (7.40 g, 20.2 mmol), DMAP (244 mg, 2.00 mmol) and MeCN (60 mL).
∗Monteiro, L. S.; Andrade, J. J.; Sua´rez, A. C. Eur. J. Org. Chem. 2011, 2011, 6764.
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The mixture was cooled to 0 ◦C and Boc2O (4.63 g, 21.2 mmol) was quickly added. Af-
ter disappearance of starting material analyzed via LC-MS, tetramethylguanidine (0.77 mL,
6.1 mmol) was added. After 12 h, the reaction mixture was concentrated under reduced
pressure and then puriﬁed by column chromatography (eluting with 20:1 DCM/MeOH) to
aﬀord the unsaturated dipeptide 8 as a white solid (6.4 g, 91%, 2 steps).
Representative hydrolysis procedure (Method C)
To a round bottom ﬂask equipped with a stir bar was added methyl ester 8 (6.40 g,
18.4 mmol), THF (90 mL), and H2O (90 mL). The mixture was cooled to 0
◦C and 1M
LiOH (aq) (19 mL, 19 mmol) was subsequently added. The reaction gradually warmed to
rt and stirred for 14 h. The reaction mixture was acidiﬁed with 10% KHSO4 (aq), and the
THF was concentrated under reduced pressure. The reaction mixture was transferred to a
separatory funnel where it was extracted with ethyl acetate (3 x 100 mL). The organic layer
was washed with 100 mL brine, dried over Na2SO4, ﬁltered, and concentrated under reduced
pressure to aﬀord the corresponding carboxylic acid as a colorless oil (6.1 g, 99%).
Representative Boc deprotection (Method D)
To a round bottom ﬂask equipped with a stir bar was added (Z )-2-((S )-2-((tert-butoxycarb-
onyl)amino)propanamido)-3-phenylacryloyl)-l-alaninate (638 mg, 1.52 mmol), triisopropyl-
silane (0.33 mL, 1.6 mmol), and DCM (15 mL). The reaction mixture was cooled to 0 ◦C
and TFA (1.17 mL, 15.2 mmol) was slowly added. The reaction slowly warmed to rt and
stirred for 24 h. The DCM was concentrated under reduced pressure and to the mixture
was added toluene to form a TFA azeotrope, which was subsequently concentrated under
reduced pressure. The reaction mixture was further dried on the high vacuum and subse-
quently triturated with Et2O to aﬀord the corresponding amine in quantitative yield which
11
was used without further puriﬁcation.
Methyl 2-((S)-2-((tert-butoxycarbonyl)amino)propanamido)-3-hydroxy-3-phenyl-
propanoate
BocHN
O
H
N OMe
OMe
OHPh
The product was prepared by method A using Boc alanine 6
(5.00 g, 26.4 mmol)and puriﬁed by column chromatography (elut-
ing with 90:10 DCM/MeOH) to aﬀord a white solid (7.4 g, 61%,
1:1 dr).
1
H-NMR: δ (499 MHz, DMSO) 7.89 (d, J = 9.1 Hz, 1H),
7.76 (d, J = 8.9 Hz, 1H), 7.45 – 7.32 (m, 4H), 7.31 – 7.24 (m, 4H), 7.25 – 7.19 (m, 2H), 7.00
(d, J = 8.0 Hz, 1H), 6.86 (d, J = 8.0 Hz, 1H), 5.92 (d, J = 4.8 Hz, 2H), 5.14 (dd, J = 4.9,
3.2 Hz, 1H), 5.12 – 5.06 (m, 1H), 4.55 (ddd, J = 12.7, 9.0, 3.2 Hz, 2H), 4.10 – 3.84 (m, 2H),
3.65 (s, 3H), 3.61 (s, 3H), 1.39 (s, 9H), 1.38 (s, 9H), 1.02 (d, J = 7.2 Hz, 3H), 0.94 (d, J =
7.2 Hz, 3H).
13
C-NMR: δ (126 MHz, DMSO) 172.96, 172.91, 170.61, 154.88, 154.82, 141.57,
141.47, 127.76, 127.73, 127.25, 127.16, 126.38, 126.14, 109.52, 78.15, 77.97, 72.22, 72.11,
58.05, 52.02, 51.99, 49.78, 49.29, 28.21, 18.30, 17.96. IR (ATR): 3337, 3013, 2978, 1660,
1498, 1365, 1168 cm−1. HRMS (ESI-TOF) m/z calculated for C18H26N2O6Na[M+Na]
+:
389.1689, found: 389.1687.
12
Methyl (S,Z )-2-(2-((tert-butoxycarbonyl)amino)propanamido)-3-phenylacrylate
(8)
BocHN
H
N
O
OMe
OMe
Ph
The product was prepared by method B using the previously
prepared methyl ester (7.40 g, 20.2 mmol) and puriﬁed by col-
umn chromatography (eluting with 93:7 DCM/MeOH) to aﬀord
the product as a white solid (6.4 g, 91%, 2 steps).
1
H-NMR: δ
(400 MHz, DMSO) 9.56 (s, 1H), 7.77 – 7.64 (m, 2H), 7.43 – 7.30 (m, 3H), 7.26 (s, 1H), 7.03
(d, J = 7.2 Hz, 1H), 4.21 – 4.05 (m, 1H), 3.70 (d, J = 1.4 Hz, 3H), 1.41 (s, 9H), 1.26 (d, J =
7.2 Hz, 3H).
13
C-NMR: δ (126 MHz, DMSO) 173.13, 165.41, 155.23, 133.31, 132.11, 130.23,
129.47, 128.49, 125.92, 78.05, 52.16, 49.82, 28.24, 17.40. IR (ATR): 3291, 3005, 2979, 1673,
1490, 1249, 1162 cm−1. HRMS (ESI-TOF) m/z calculated for C18H24N2O5Na [M+Na]
+:
371.1583, found: 371.1588. [α]24D +66 (c = 0.46, MeOH).
(S,Z )-2-(2-((tert-butoxycarbonyl)amino)propanamido)-3-phenylacrylic acid
BocHN
H
N
O
OH
OMe
Ph
The product was prepared by method C using unsaturated dipep-
tide 8) (6.40 g, 18.4 mmol) and obtained as a white solid (6.0 g,
99%).
1
H-NMR: δ (500 MHz, DMSO) 12.68 (s, 1H), 9.39 (s, 1H),
7.76 – 7.55 (m, 2H), 7.42 – 7.32 (m, 3H), 7.28 (s, 1H), 7.02 (d,
J = 7.3 Hz, 1H), 4.21 – 4.05 (m, 1H), 1.40 (s, 9H), 1.25 (d, J = 7.2 Hz, 3H).
13
C-NMR:
δ (126 MHz, CDCl3) 172.66, 166.30, 155.21, 133.68, 131.83, 130.14, 129.19, 128.39, 126.52,
78.03, 49.83, 28.25, 17.52. IR (ATR): 3281, 2980, 1685, 1539, 1162 cm−1 HRMS (ESI-TOF)
m/z calculated for C17H22N2O5Na [M+Na]
+: 357.1426, found: 357.1419. [α]25D +70 (c =
0.25, MeOH).
13
Methyl ((Z )-2-((S)-2-((tert-butoxycarbonyl)amino)propanamido)-3-phenylacryl-
oyl)-L-alaninate
BocHN
H
N
O
N
H
OMe
Ph
Me
OMe
O
The product was prepared by method A using the previously
prepared carboxylic acid (3.80 g, 11.4 mmol), l-alanine methyl
ester (1.60 g, 11.4 mmol), and i -Pr2EtN (7.90 mL, 45.6 mmol)
and puriﬁed by column chromatography (eluting with 85:15
DCM/Acetone) to aﬀord the product as a white solid (3.0 g, 64%).
1
H-NMR: δ (499 MHz,
DMSO) 9.57 (s, 1H), 7.93 (d, J = 6.8 Hz, 1H), 7.65 – 7.49 (m, 2H), 7.42 – 7.31 (m, 3H),
7.25 (s, 1H), 7.21 (m, 1H), 4.44 – 4.34 (m, 1H), 4.08 – 3.99 (m, 1H), 3.64 (s, 3H), 1.39 (s,
9H), 1.34 (d, J = 7.2 Hz, 3H), 1.23 (d, J = 7.1 Hz, 3H).
13
C-NMR: δ (126 MHz, DMSO)
172.75, 172.71, 164.34, 155.71, 133.83, 130.04, 129.58, 128.84, 128.47, 128.39, 78.35, 51.86,
50.06, 48.23, 28.19, 16.93, 16.71. IR (ATR): 3291, 3017, 2981, 1751, 1685, 1530, 1163 cm−1.
HRMS (ESI-TOF) m/z calculated for C21H29N3O6Na [M+Na]
+: 442.1954, found: 442.1946.
[α]25D –41 (c = 0.25, MeOH).
Methyl ((Z )-2-((S)-2-aminopropanamido)-3-phenylacryloyl)-L-alaninate 4
H2N
H
N
O
N
H
OMe
Ph
Me
OMe
O
TFA
The product was prepared by method D using the previously
prepared tripeptide (5.60 g, 13.3 mmol) and obtained as a white
solid in quantitative yield.
1
H-NMR: δ (499 MHz, DMSO) 9.95
(s, 1H), 8.46 (d, J = 7.1 Hz, 1H), 8.22 – 8.14 (m, 2H), 7.60 – 7.52
(m, 2H), 7.49 – 7.39 (m, 2H), 7.38 – 7.33 (m, 1H), 7.16 (s, 1H), 4.41 (p, J = 7.2 Hz, 1H), 4.11
– 4.01 (m, 1H), 3.65 (s, 3H), 1.44 (d, J = 7.0 Hz, 3H), 1.35 (d, J = 7.3 Hz, 3H).
13
C-NMR:
δ (126 MHz, DMSO) 172.95, 169.08, 164.31, 133.67, 129.40, 129.08, 128.91, 128.55, 128.34,
51.91, 48.47, 48.12, 16.87, 16.42. IR (ATR): 2996, 1740, 1660, 1519, 1137 cm−1. HRMS
(ESI-TOF) m/z calculated for C16H21N3O4H [M+H]
+: 320.1610, found: 320.1620. [α]26D
14
+90 (c = 0.31, MeOH).
Methyl ((Z )-2-((S)-2-((S)-2-(2-((tert-butoxycarbonyl)amino)acetamido)-3-(4-hy-
droxyphenyl)propanamido)propanamido)-3-phenylacryloyl)-L-alaninate
N
H
H
N
O
N
H
OMe
Ph
Me
OMe
O
OH
N
O
BocHN
HO
To a round botton ﬂask equipped with a stir bar was added (tert-
butoxycarbonyl)glycyl-l-tyrosine (4.10 g, 12.2 mmol), amine 4
(4.80 g, 11.1 mmol), HATU (5.00 g, 13.3 mmol), HOAt (0.452 g,
3.32 mmol) and DMF (42 mL). The reaction mixture was cooled
to 0 ◦C and 2,4,6-collidine (3.70 mL, 27.7 mmol) was added. The reaction warmed to rt
and stirred for 24 h. The solvent was removed under reduced pressure and the product was
puriﬁed by column chromatography (eluting with 90:10 DCM/MeOH, increasing in 0.5%
increments) to aﬀord the product as a white solid (4.32 g, 61%).
1
H-NMR: δ (500 MHz,
DMSO) 9.66 (s, 1H), 9.16 (s, 1H), 8.47 (d, J = 5.1 Hz, 1H), 8.00 (d, J = 6.3 Hz, 1H), 7.65 (d,
J = 8.2 Hz, 1H), 7.61 – 7.53 (m, 2H), 7.44 – 7.37 (m, 2H), 7.38 – 7.32 (m, 1H), 7.27 (s, 1H),
6.98 (d, J = 8.2 Hz, 2H), 6.94 (t, J = 6.2 Hz, 1H), 6.60 (d, J = 8.4 Hz, 2H), 4.48 (td, J =
8.4, 4.3 Hz, 1H), 4.40 – 4.18 (m, 2H), 3.64 (s, 3H), 3.54 (dd, J = 16.8, 6.1 Hz, 1H), 3.43 (dd,
J = 16.8, 6.0 Hz, 1H), 2.88 (dd, J = 14.1, 4.3 Hz, 1H), 2.67 (dd, J = 14.1, 8.6 Hz, 1H), 1.36
(s, 9H), 1.31 (d, J = 7.1 Hz, 3H), 1.26 (d, J = 7.3 Hz, 3H).
13
C-NMR: δ (126 MHz, DMSO)
173.10, 172.16, 171.74, 169.06, 164.27, 155.84, 155.80, 133.82, 130.25, 130.22, 129.58, 128.94,
128.51, 128.40, 127.33, 114.84, 78.15, 53.39, 51.86, 49.24, 48.52, 43.26, 36.74, 28.17, 16.66,
16.49. IR (ATR): 3305, 2974, 1656, 1514, 1160 cm−1. HRMS (ESI-TOF) m/z calculated for
C32H41N5O9Na [M+Na]
+: 662.2802, found: 662.2817. [α]26D –82 (c = 0.25, MeOH).
15
((Z )-2-((S)-2-((S)-2-(2-aminoacetamido)-3-(4-hydroxyphenyl)propanamido)pro-
panamido)-3-phenylacryloyl)-L-alanine 3
N
H
H
N
O
N
H
OMe
Ph
Me
OH
O
OH
N
O
H2N
HO
TFA
To a round bottom ﬂask equipped with a stir bar was added
the previously prepared methyl ester (4.20 g, 6.60 mmol), THF
(30 mL), and H2O (30 mL). The mixture was cooled to 0
◦C and
1M LiOH (aq) (7.26 mL, 7.26 mmol) was subsequently added.
The reaction gradually warmed to rt and stirred for 48 h. The reaction mixture was acidiﬁed
with 10% KHSO4 (aq) and the THF was concentrated under reduced pressure. The reaction
mixture was transferred to a separatory funnel where it was extracted with ethyl acetate (3 x
100 mL). The organic layer was washed with 100 mL brine, dried over Na2SO4, ﬁltered, and
concentrated under reduced pressure to aﬀord the corresponding carboxylic acid which was
used in the next step without further puriﬁcation. To a round bottom ﬂask equipped with a
stir bar was added the previously prepared carboxylic acid (6.60 mmol), and DCM (60 mL).
The reaction mixture was cooled to 0 ◦C and TFA (5.1 mL, 66 mmol) was slowly added.
The reaction slowly warmed to rt and stirred for 14 h. The DCM was concentrated under
reduced pressure and to the mixture was added toluene to form a TFA azeotrope, which was
subsequently concentrated under reduced pressure. The reaction mixture was further dried
on the high vacuum and subsequently triturated with Et2O to aﬀord unsaturated peptide
3 (4.0 g, 97% 2 steps).
1
H-NMR: δ (500 MHz, DMSO) 9.62 (s, 1H), 9.22 (s, 1H), 8.56 (d,
J = 5.7 Hz, 1H, N–HAla(term)), 8.52 (d, J = 8.4 Hz, 1H, N–HTyr), 7.91 (d, J = 6.9 Hz, 3H,
N–HAla(int)+Gly), 7.57 (d, J = 7.7 Hz, 2H), 7.42 – 7.30 (m, 3H), 7.22 (s, 1H), 7.04 (d, J =
8.1 Hz, 2H), 6.64 (d, J = 8.0 Hz, 2H), 4.56 (td, J = 9.2, 3.7 Hz, 1H), 4.39 – 4.22 (m, 2H),
3.55 (d, J = 16.2 Hz, 1H), 3.43 (d, J = 16.2 Hz, 1H), 2.93 (dd, J = 14.2, 3.8 Hz, 1H), 2.59
(dd, J = 14.1, 10.1 Hz, 1H), 1.36 (d, J = 7.3 Hz, 3H), 1.31 (d, J = 7.1 Hz, 3H).
13
C-NMR:
δ (126 MHz, DMSO) 174.22, 172.30, 171.59, 165.91, 164.30, 156.09, 134.02, 130.22, 129.90,
129.71, 129.02, 128.81, 128.64, 127.69, 115.13, 54.36, 49.29, 48.38, 40.19, 36.94, 17.25, 16.84.
16
IR (ATR): 3270, 1656, 1515, 1172 cm−1. HRMS (ESI-TOF)m/z calculated for C26H31N5O7H
[M+H]+: 526.2302, found: 526.2303. [α]26D -20 (c = 0.23, MeOH).
Methyl 2-amino-2-(dimethoxyphosphoryl)acetate
H2N OMe
O
P O(MeO)2
TFA
To a round bottom ﬂask equipped with a stir bar was added
methyl 2-((tert-butoxycarbonyl)amino)-2-(dimethoxyphosphoryl)acetate
(10 g, 32 mmol) and DCM (340 mL). The reaction cooled to 0 ◦C
and TFA was subsequently added dropwise. The reaction warmed
to rt and stirred for 16 h. The DCM was concentrated under re-
duced pressure and toluene was added to form a TFA azeotrope, which was subsequently
concentrated under reduced pressure. The unpuriﬁed reaction mixture was further dried on
the high vacuum and subsequently triturated with Et2O to aﬀord the product in quantita-
tive yield which was used without further puriﬁcation.
1
H-NMR: δ (500 MHz, DMSO) 9.04
(s, 2H), 5.04 (d, J = 20.5 Hz, 1H), 3.83 – 3.73 (m, 9H).
13
C-NMR: δ (126 MHz, DMSO)
165.20 (d, J = 3.7 Hz), 54.58 (d, J = 6.5 Hz), 54.39 (d, J = 6.4 Hz), 53.63, 49.18 (d, J =
140.8 Hz). IR (ATR): 2975, 2869, 1761, 1218, 1140 cm−1. HRMS (ESI-TOF) m/z calculated
for C5H12NO5PNa [M+Na]
+: 220.0351, found: 220.0355.
Methyl 2-((S)-2-((tert-butoxycarbonyl)amino)propanamido)-2-(dimethoxyphos-
phoryl)acetate
H
N OMe
O
P O
(MeO)2
BocHN
Me
O
The herein described dipeptide was prepared according to method
A using the previously prepared amine (6.3 g, 32 mmol), and
Boc-l-Ala-OH (6.36 g, 33.6 mmol) and puriﬁed by column chro-
matography to aﬀord the product as a white solid (8.1 g, 69%,
1:1 dr).
1
H-NMR: δ (500 MHz, DMSO) 8.67 – 8.54 (m, 1H), 7.02 (dd, J = 13.1, 7.9 Hz,
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1H), 5.27 – 4.80 (m, 1H), 4.26 – 3.95 (m, 1H), 3.83 – 3.50 (m, 9H), 1.37 (s, 9H), 1.17 (dd,
J = 7.3, 3.1 Hz, 3H).
13
C-NMR: δ (126 MHz, DMSO) 173.43 , 173.37 , 173.17 , 173.12 ,
167.03 (d, J = 2.7 Hz), 166.92 (d, J = 3.0 Hz), 155.06 , 155.00 , 78.08 , 78.05 , 54.04 (d,
J = 6.6 Hz), 53.81 (d, J = 5.8 Hz), 53.78 (d, J = 6.8 Hz), 53.75 (d, J = 5.5 Hz), 52.88 ,
52.86 , 49.66 (d, J = 147.2 Hz), 49.64 (d, J = 146.3 Hz), 49.32 , 28.19 , 18.08 , 17.86. IR
(ATR): 3005, 2970, 2935, 1749, 1674, 1506, 1249, 1163, 1075 cm−1. HRMS (ESI-TOF) m/z
calculated for C13H25N2O8PNa [M+Na]
+: 391.1246, found: 391.1248.
Methyl (S,Z )-2-(2-((tert-butoxycarbonyl)amino)propanamido)-3-cyclohexylacry-
late
H
N OMe
O
BocHN
Me
O
The Horner-Wadsworths-Emmons product was prepared accord-
ing to an adapted procedure reported by Schmidt.∗† To a solution
of the previously prepared dipeptide (8.1 g, 22 mmol) in DCM
(73 mL) at 0 ◦C was added DBU (4.0 mL, 26 mmol). After 10
min, cyclohexanecarbaldehyde (3 g, 26.7 mmol) was added and
the reaction mixture stirred at rt for 24 h. The reaction mixture was transferred to a separa-
tory funnel and washed with 100 mL sat. NaHCO3 (aq), 100 mL 10% KHSO4, and 100 mL
brine. The organic phase was dried over Na2SO4, ﬁltered, and concentrated under reduced
pressure. The reaction mixture was then puriﬁed by column chromatography (eluting with
3:7 hexanes/ethyl acetate) to aﬀord the product as a white solid (7.2 g, 92%).
1
H-NMR: δ
(500 MHz, DMSO) 9.08 (s, 1H), 6.93 (d, J = 7.4 Hz, 1H), 6.27 (d, J = 10.0 Hz, 1H), 4.10 –
3.98 (m, 1H), 3.62 (s, 3H), 2.38 – 2.24 (m, 1H), 1.70 – 1.52 (m, 5H), 1.38 (s, 9H), 1.22 (d, J
= 7.3 Hz, 4H), 1.19 – 1.02 (m, 4H).
13
C-NMR: δ (126 MHz, DMSO) 172.50, 164.85, 155.04,
142.22, 125.30, 77.95, 51.80, 49.62, 35.98, 31.06, 30.96, 28.20, 25.32, 25.04, 24.99, 17.90.
∗Schmidt, U.; Griesser, H.; Leitenberger, V.; Liebenknecht, A.; Mangold, R.; Meyer, R.; Reidl, B.
Synthesis 1992, 487.
†Burk, M. J.; Johnson, N. B.; Lee, J. R. Tetrahedron Lett. 1990, 40, 6685.
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IR (ATR): 2984, 2929, 2850, 1719, 1674, 1506, 1258, 1225, 1162 cm−1. HRMS (ESI-TOF)
m/z calculated for C18H30N2O5Na [M+Na]
+: 377.2052, found: 377.2048. [α]25D -5 (c = 0.55,
MeOH).
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Methyl ((Z )-2-((2S)-2-(2-(2-((tert-butoxycarbonyl)amino)acetamido)-3-(4-hydro-
xyphenyl)propanamido)propanamido)-3-cyclohexylacryloyl)-L-alaninate
H
N N
H
O
N
H
Me
O
Me
OMe
O
OH
N
O
BocHN
HO
The previously prepared tripeptide (6.2 g, 15 mmol) was depro-
tected according to general procedure D to aﬀord the correspond-
ing amine in quantitative yield which was used without further
puriﬁcation. To a round bottom ﬂask equipped with a stir bar
was added (tert-butoxycarbonyl)glycyl-l-tyrosine (4.7 g, 14 mmol), the previously prepared
amine (15 mmol), HATU (5.3 g, 14 mmol), HOAt (0.50 g, 4.0 mmol) and DCM (49 mL).
The reaction mixture was cooled to 0 ◦C and iPr2EtN (5.5 mL, 32 mmol) was added. The
reaction was warmed to rt and stirred for 24 h. The solvent was removed under reduced
pressure and the product was puriﬁed by column chromatography (eluting with 95:5 ethyl
acetate/acetone) to aﬀord the product as a white solid (1.8 g, 22%).
1
H-NMR: δ (400 MHz,
DMSO) 9.19 – 8.97 (m, 2H), 8.36 (d, J = 5.5 Hz, 1H), 7.73 (d, J = 6.6 Hz, 1H), 7.66 (d, J
= 8.2 Hz, 1H), 6.98 (d, J = 8.0 Hz, 2H), 6.60 (d, J = 7.4 Hz, 2H), 6.29 (d, J = 8.3 Hz, 1H),
4.59 – 4.39 (m, 1H), 4.33 – 4.17 (m, 2H), 3.61 (s, 3H), 3.56 – 3.48 (m, 1H), 3.48 – 3.37 (m,
1H), 3.38 – 3.33 (m, 1H), 2.93 – 2.84 (m, 1H), 2.75 – 2.61 (m, 1H), 2.22 (d, J = 11.3 Hz, 1H),
1.74 – 1.53 (m, 5H), 1.36 (s, 9H), 1.28 (d, J = 6.6 Hz, 3H), 1.23 (d, J = 7.2 Hz, 4H), 1.20 –
1.03 (m, 4H).
13
C-NMR: δ (126 MHz, DMSO) 173.12, 171.98, 171.52, 169.07, 163.85, 155.82,
155.79, 139.61, 130.21, 127.41, 127.37, 114.84, 78.14, 59.79, 53.49, 51.83, 49.06, 48.19, 43.25,
36.06, 31.24, 28.16, 25.41, 25.15, 20.79, 17.25, 16.73, 14.12. IR (ATR): 3003, 2984, 2929,
2850, 1751, 1686, 1510, 1150 cm−1. HRMS (ESI-TOF) m/z calculated for C32H47N5O9Na
[M+Na]+: 668.3271, found: 668.3270. [α]25D -33 (c = 0.25, MeOH).
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1.2.2 2D NOESY Spectroscopy
2D NOESY experiments were performed on a 500 MHz Bruker DRX500 spectrometer with
a TCI cryoprobe with 2 number of scans, 800 ms mixing time, 2 s relaxation delay, and a
spectral width of 8012.8 Hz.
H2N
NH HN
HN
HN
O
O
O
O
O
Me
Me
Ph
HO
O
H
H
H
H
H
H
H
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1.2.3 Molecular modeling using Maestro
Structures with all experimentally feasible combinations of HNHα φ dihedral angles for Tyr,
Ala (internal) and Ala (terminal) were simulated in no solvent but with a dielectric constant
corresponding to that of DMSO (47.6) using Maestro (Schrodinger, Inc.).∗ An error of ±
40◦ was added to every structure. Only weak and very weak distance restraints found from
NOESY spectrum using a mixing time of 800 ms were also included in the simulations. The
cross-peak volumes were classiﬁed as weak (upper distance constraint ≤ 5) and very weak
(upper distance constraint ≤ 6). The 19 lowest-energy structures are displayed.
1 2
3 4
∗Schro¨dinger Release 2015-2: Maestro, version 10.2, Schro¨dinger, LLC, new York, NY, 2015
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Chapter 2
Cobalt-Catalyzed Hydroacylation to
from Thermodynamically Unfavored
Motifs∗
∗Reproduced in part with permission from Kim, D. D.; Riedel, J.; Kim, R., S.; Dong, V. M. J. Am.
Chem. Soc. 2017, 139, 10208. Copyright 2017 American Chemical Society
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2.1 Enantioselective Cyclobutatone Synthesis
2.1.1 Introduction
Metalloenzymes can transform simple oleﬁns into a diverse array of cyclic natural products.55
For example, an achiral building block such as geranyl pyrophosphate undergoes ring-closing
to generate a range of enantiopure terpenoids (e.g., sabinene, limonene, camphene, and
pinene) (Figure 2.1). Considering Nature’s ability to construct various rings via cyclases,56
we aim to diversify common building blocks into diﬀerent cyclic isomers, with high enantios-
electivity via synthetic catalysts.57,58 As an analogue to geranyl pyrophosphate, we designed
a simple model, dienyl aldehyde (19), that can be accessed in one step from commercial
materials.59 When using Rh-catalysis, we can transform this achiral aldehyde into the cor-
responding cyclopentanone (23), bicycloheptanone (21), or cyclohexenal (22) scaﬀold, by
tuning the ligand scaﬀold (Figure 2.1).57,58 Herein, we report a cobalt catalyst that enables
ring closing to generate the four-membered ring (24) via enantioselective hydroacylation.
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Me
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Me
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Figure 2.1. Inspiration for cobalt-based cyclase mimic
Hydroacylation60 (the addition of an aldehyde C–H bond across an oleﬁn or alkyne) enables
C–C bond formation with excellent atom economy.61,62 Most intramolecular variants provide
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exclusive access to cyclopentanones in preference to cyclobutanones.60 However, there are
two exceptions, both of which use substrates bearing a methoxy-directing group under Rh-
catalysis.63 Fu’s method achieves an enantioenriched mixture of four- and ﬁve-membered
ketones via a parallel kinetic resolution. A¨ıssa observed a 12% yield of the four-membered
ketone when performing a similar parallel kinetic resolution. Rather than relying on a
precious metal or a kinetic resolution, we propose using a base-metal (Co) to overturn the
usual regioselectivity of hydroacylation to favor the more strained ring.
(b)
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Figure 2.2. Challenges and literature precedents
Both Rh and Co are known to activate aldehyde C–H bonds through oxidative addition
to form an acyl-metal-hydride intermediate 25 (Figure 2.2).60,64–68 From this intermediate,
oleﬁn insertion results in an equilibrium mixture of the six- (26) and ﬁve-membered (27)
metallacycles. In general, reductive elimination from 26 is thermodynamically and kinet-
ically favored to generate the less strained cyclopentanone product.69 Moreover, achieving
reductive elimination from a ﬁve-membered metallacycle (27) is challenging due to compet-
itive endocyclic β-hydride elimination.70,71 By using ﬁrst-row metals, however, C–C bond
forming reductive eliminations from 28 to make small strained rings have been observed
(Figure 2.2).70–86 Most relevant to our study, Bergman characterized a cobaltacycle (29),
that upon treatment with stoichiometric FeCl3 undergoes reductive elimination to form cy-
clobutanone (30).73 Encouraged by these breakthroughs, we set out to identify the ﬁrst
cobalt-catalyst capable of generating cyclobutanones.
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2.1.2 Results and Discussion
In our initial study, we found that commercially available CoI-catalysts, such as Co(PPh3)3Cl,
result in no conversion to the desired cyclobutanone (Table 2.1). However, with Co(PPh3)3Cl,
in the presence of a zinc reductant, we observe a 5% yield and 6:1 regioisomeric ratio (rr) of
24a:31a. We postulate that the reductant transforms the CoI-complex into a Co0-catalyst
critical for reactivity.
Table 2.1. Identifying catalyst for cyclobutanones
H
O
Ph
O
Me
PhCon-catalyst
MeCN, 50 °C, 24 h
O
Ph
+
entry Con-catalyst reductant yield
1
2
4
5
none
Zn (10 mol%)
Et2Zn (50 mol%)
Zn (10 mol%)
0%
5%
ee n.d.
89%
92% ee
93%
92% ee
(PPh3)3CoICl (5 mol%)
+ BDPP (5 mol%)
(PPh3)3CoICl (5 mol%)
+ BDPP (5 mol%)
(BDPP)CoIICl2 (10 mol%)
(BDPP)CoIICl2 (2 mol%)
3 none 10%
ee n.d.(PMe3)4Co0 (5 mol%)
selectivity
rr n.d.
dr n.d.
6:1 rr
>20:1 dr
1:1 rr
1:1 dr
10:1 rr
10:1 dr
>20:1 rr
>20:1 dr
19a 24a 31a
24a
Indeed, using a well-characterized and isolable Co(PMe3)4 (synthesized from CoCl2, sodium
naphthalenide, and trimethylphosphine) results in a mixture of 24a and 31a in 1:1 rr in
10% yield. Switching to a CoCl2/reductant system,
87,88 as a precursor for Co0, enabled rapid
evaluation of a range of chiral phosphine ligands.∗ Under these conditions, we identiﬁed a
chiral ligand, (S,S )-2,4-bis(diphenylphosphino)- pentane (BDPP), that promotes the forma-
tion of 24a in preference to 31a. A catalyst loading of 10 mol% using diethyl zinc as the
reducing agent gave promising selectivities (10:1 dr, 10:1 rr). Moreover, by desymmetriza-
tion, we access these motifs with 92% ee using this chiral bidentate phosphine ligand. On
the basis of 1H NMR studies, we observe evolution of ethylene and ethane gas when using
diethyl zinc. This observation is consistent with formation of a Co0-species. For a proposed
∗For a comprehensive list of ligands evaluated, see SI. For synthesis of [(S,S )-BDPP]CoCl2 see Sharma,
R. S.; RajanBabu, T. V. J. Am. Chem. Soc. 2010, 132, 3295.
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mechanism, 1H NMR, and UV/vis absorption spectra data for the formation of Co0-species
using diethyl zinc (see SI). The catalyst loading can be lowered to 2 mol% when switching
to activated zinc metal as a stronger reducing agent. The use of activated zinc improves
reactivity (from 24 to 4 h) and selectivity (from 10:1 dr and rr to >20:1 dr and rr) when
using 10 mol% of the catalyst.
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Figure 2.3. Proposed mechanism
Related protocols for Co-hydroacylation have been proposed to occur through Co0/CoII and
CoI/CoIII catalytic cycles.64,66–68 Although both are feasible, on the basis of our results, we
propose this cyclization occurs by initial reduction of CoII-chloride to a Co0-complex (35),
with activated zinc or diethyl zinc (Figure 2.3). The Co0-catalyst then binds to the substrate
(19) to form complex (32) prior to aldehyde C–H bond activation by oxidative addition. The
acyl-Co-hydride intermediate (33) can isomerize by oleﬁn insertion into the metal-hydride
bond to forge the ﬁve-membered metallacycle (35). From here, reductive elimination forms
the C–C bond to construct the strained ring (24).
Under these mild conditions, a variety of α-aryl dienyl aldehydes undergo isomerization to
the corresponding cyclobutanones (Table 2.2). Dienyl aldehydes bearing electron-rich α- aro-
matic groups (alkyls, ethers, acetals, and alcohols) ring close in good yields and selectivities
(76-93% yields, >89% ee, >10:1 dr, >10:1 rr). Substrates with electron-poor α-aromatic
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groups (F, Cl, and CF3) also cyclize (91-85% yield, >64% ee, >13:1 dr, and >9:1 rr) albeit
with lower enantioselectivities. Heteroaryl thiophene, silylated phenol, and amine substrates
are well tolerated (60-92% yield, 82-95% ee, >11:1 dr, >9:1 rr). Of note, cyclobutanone 24a
was generated on gram scale without impact on selectivity.
Table 2.2. Synthesis of enantioenriched cyclobutanones
 76% yield, 92% ee
 >20:1 dr, >20:1 rr
O
Me
92% yield
83% ee
11:1 dr, 12:1 rr
O
Me
92% yield
93% ee
17:1 dr, 13:1 rr
O
Me
92% yield
93% ee
15:1 dr, 13:1 rr
O
Me
O
O
S
R
H
O [(S,S)-BDPP]CoCl2 (2 mol%)
Zn (10 mol%)
MeCN, 50 °C, 24 h
R O
Me
O
R
4-Me: 93% yield, 89% ee, 19:1 dr, 15:1 rr
4-OMe: 93% yield, 90% ee, 10:1 dr, 15:1 rr
4-Ph: 76% yield, 92% ee, 20:1 dr, 10:1 rr
4-F: 91% yield, 91% ee, 15:1 dr, 13:1 rr
4-Cl: 85% yield, 91% ee, 20:1 dr, 10:1 rr
4-TMS: 62% yield, 91% ee, >20:1 dr, 10:1 rr
4-OTBS: 62% yield, 92% ee, >20:1 dr, 10:1 rr
4-CF3: 85% yield, 64% ee, 13:1 dr, 9:1 rr
3-OMe: 76% yield, 90% ee, 20:1 dr, 10:1 rr
3-Me: 91% yield, 96% ee, 15:1 dr, 13:1 rr
O
Me
R
R=
65% yield  
89% ee
>20:1 dr, 9:1 rr
                
60% yield
82% ee
>20:1 dr, 9:1 rr
O
Me
X
PhX
X = NO X = Br
     
15% yield
+
58% yield 
69%  
(31% biphenyl)
X = NO X = Br
side-by-side evaluation
19 24 31
24a
24b
24c
24d
24e
24f
24g
24h
24i
24j
24k
24l
24m 24n
19o 24o 19p 24p
19a
36
19a 24a
24a
19a 24a
24a
36b
36a 36b
We imagined that an aryl group bearing a range of functional groups could be tolerated
in this transformation. To probe this idea, we performed a functional group compatibility
test.89–91 We added an equivalent amount of various additives (e.g., pyridine, phenol, amines,
etc.) with aldehyde (19a) under otherwise standard conditions.∗ The cyclization to cyclobu-
tanone (24a) occurs smoothly in the presence of heterocycles such as pyridines and indoles.
Additives containing polar protic functional groups such as phenols, anilines, and amides as
well as other carbonyl-containing additives such as aldehydes, ketones, esters, and amides
had little eﬀect on the transformation.
The robustness screen provides a general guideline to the selectivities and to the types of
functional groups tolerated in our reaction,89–91 although selectivities can vary depending on
∗For a comprehensive list of functional groups evaluated and reaction outcomes under standard reaction
conditions with 19a, see SI
31
where the functional group is attached. For example, we found that the addition of morpho-
line additive (36a) yielded 24a in 65% yield and 89% ee. We prepared the analogous mor-
pholine containing substrate (19o) and performed the cyclization to provide cyclobutanone
(24o) in similar yield but slightly lower ee.92–94 In contrast, an aryl-bromide containing addi-
tive (36b) and 4-bromophenyldienyl aldehyde (19p) both underwent debromination to form
biphenyl and 19a, respectively. Our cyclization proceeds well in the presence of known radi-
cal inhibitors such as butylated hydroxytoluene (BHT),95 9,10-dihydroanthracene (DHA),96
and 1,1-diphenylethylene (DPE) (84% yield, 93% ee, >20:1 dr, 7:1 rr, with 94% additive
recovered). The use of TEMPO as an additive inhibited reactivity presumably acting as an
oxidant as well as a ligand on Co.97
When using deuterium-labeled aldehyde 19a-D, we observe full incorporation of the deu-
teride into the α-methyl position of the cyclobutanone product 24a-D (Figure 2.4). This
isotopic labeling study provides results consistent with our proposed mechanism (Figure 2.3).
When comparing the measured initial rates of two parallel reactions between the protio-
aldehyde (19a) and deuterio-aldehyde (19a-D), we observe a primary kinetic isotope eﬀect
of 2.7 (KIE = 2.7). When monitoring the reaction with 19a-D as the substrate, no deu-
terium scrambling in the product or the starting material was observed. The primary KIE
alongside a lack of deuterium scrambling likely points to aldehyde C–H bond activation or
oleﬁn insertion into the Co–H bond as the turnover-limiting step.
By studying the scope of this cyclization, we found that regioisomeric ratio (rr) of 5:6 is
inﬂuenced by the α-position of the aldehyde (Figure 2.4). Higher selectivity for the four-
membered versus ﬁve-membered ketone is observed with increasing size of the α-substituent
(R in Figure 2.4). The highest selectivity is observed with phenyldienyl aldehyde 19a (>20:1
rr, A-value = 3.0 for R = Ph) and the lowest selectivity is observed with dienyl aldehyde
19r (1:2 rr, A-value = 0.0 for R = H).98 We reason that the increased steric crowding
around the metal center promotes formation of the ﬁve-membered metallacycle 27 over the
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Figure 2.4. Reaction evaluation of dienyl aldehyde
six-membered metallacycle 26.99 This is due to bond-angle compression, making the ﬁve-
membered metallacycle 27 more thermodynamically stable and kinetically accessible. Thus,
despite ring-strain, reductive elimination to form the four-membered ring is not turnover-
limiting. Therefore, we propose that oleﬁn insertion is turnover-limiting and favors formation
of the ﬁve-membered metallacycle.
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Figure 2.5. Derivatization of cyclobutanone 24a
The newly formed stereocenters in our cyclobutanone scaﬀold can be put to use in a number
of stereoselective reactions to build diﬀerent structures (Figure 2.5). The reduction to the
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secondary alcohol can be controlled depending on choice of the reductant. DIBAL-H adds
from the more sterically hindered face (a), whereas L-selectride adds from the less hindered
face (b). This strained ketone can be converted to an enol-triﬂate suitable for cross-coupling
reactions (c). A strained ketimine can be prepared by condensation with 2,4- dinitrohy-
drazine (d). New C-C bonds can be generated in a highly diastereoselective fashion (>20:1)
by using vinyl- (e) or phenyl-Grignard (f) addition to generate the tertiary cyclobutanols.
Taking advantage of the ring-strain,100 the cyclobutanones can undergo ring-expansion to
enantioenriched cyclopentanones with vicinal all-carbon quaternary centers by addition of
isopropenylmagnesium bromide (g) followed by electrophilic bromination (h). Similarly,
the addition of a lithiated-dihydrofuran followed by treatment with mild acid results in a
one-carbon ring expansion to form a cyclopentanone (i). This spirocyclopentanone was crys-
tallized and a molecular structure was unambiguously determined by X-ray crystallography
along with assignment of the absolute stereochemistry of the cyclobutanone products 24a-o
by analogy.
Although it is not depicted, the unreacted allyl-moiety could also be used as an addi-
tional functional handle. Although cycloadditions are typically used to make four-membered
rings, cyclobutanones bearing α-quaternary carbons are challenging to access, especially with
high enantiocontrol.101–104 Our approach features a Co-catalyst that can isomerize a simple,
prochiral dienyl aldehyde into cyclobutanones bearing chiral α-quaternary carbon centers,
with excellent diastereo-, regio-, and enantiocontrol. Mechanistic studies suggest a path-
way involving a Co0/CoII cycle that is triggered by C–H bond activation. A switch from
a precious metal to an abundant base-metal enables a shift in the construction of strained
rings.
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2.2 Selective Synthesis of trans-Hydrindanones
2.2.1 Introduction
Academia and industry are targeting increasingly complex molecular architectures, while
trying to uphold high standards in eﬃciency.62 One emerging strategy to build up com-
plexity is the breakage of symmetry105 in molecules, it is believed that the homochirality of
biomolecules resulted from such a symmerty breaking event.106 In a synthetic setting, the
breakage of symmetry can be achieved by the use of chiral cataylsts that can diﬀerentiate
two faces of a prochiral molecule and selectively let only one face of molecule undergo a
reaction.107–114 This strategy has been applied in the total synthesis of (–)-cyanthiwigin F
by the Stoltz group.115
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Figure 2.6. Chemical space from the desymmetrization of cyclohexenaldehydes
Another important aspect of eﬃcient synthesis is the minimization of waste- and byprod-
ucts.116,117 The ideal process would be a catalyst enabled isomerization reaction, where all
the atoms of the starting material end up in the product.61 Combining the idea of an eco-
nomical isomerization and a complexity-introducing desymmetrization, a variety of diﬀer-
ent complex motifs can be built up quickly.57,58,118 I focused on a class of cyclohexenals
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(45). Depending on the ring size and the linkage between the ring and the aldehyde, a
variety of diﬀerent motifs could be realized through metal catalyzed cycloisomerizations
(Figure 2.6). Of special interest is hydrindanone 53. Hydrindane cores are prevalent mo-
tifs in bioactive molecules and important intermediates in total syntheses.119–125 Tradition-
ally, they have been accessed in numerous total syntheses through the Hajos-Parrish ketone
(Figure 2.7).126–132 The cis-hydrindanone can be easily accessed through a desymmetriza-
tion of a α,α-disubstituted 1,3-cyclohexanedione.133–135 Methods to make the corresponding
trans-hydrindanone are scar(also nagata hydrocyonation)136–141 although there are several
families of natural products containing this tans-fused ring system.142,143 Asymmetric cobalt
catalyzed hydroacylation can provide an attractive solution to access these motifs.118
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Me
Me
Me
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Figure 2.7. Natural motifs containing hydrindane skeletone
We envisioned that a cobalt catalyst could be able to take cyclohexenal 45 form a C-C
bond though intramolecular hydroacylation, resulting in hydrindanone 53 or the isomeric
four-membered fused ring system 52.
2.2.2 Results and Discussion
To test our hypothesis, cyclohexenal 53a was prepared by using 1,3-cyclohexandione 6 and
doing a Knoevenhagel-condensation with benzaldehyde, followed by a Hantzsch-ester re-
duction in one pot, giving benzylated 1,3-cyclohexandione 7.144 Initally, intermediate 7 was
alkylated with with methyl bromoacetate, but the following oleﬁnation proved to be challeng-
ing (see SI). Next, intermediate 7 was allylated with allyl bromide to aﬀord the disubstituted
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1,3-cyclohexandione 8. Although bearing an α quaternary center, the ketones could be con-
verted into the corresponding oleﬁns, using standard Wittig oleﬁnation conditions, giving
cyclohexene 9. From there, a sequence of dihydroxylation with OsO4 and oxidative cleavage
with NaIO4 aﬀorded the desired cyclohexenal 53a.
O O O O
Ph
O O
Ph
PhPh
OH
OH
Ph
O
conditions conditions conditions
conditionsconditions
6 7 8
91045a
Figure 2.8. Substrate synthesis
With cyclohexenal 53a in hand, I tested the key reaction as shown in Figure 2.9. When
using CoCl2 as precatalyst, zinc as reductant and dppe as the ligand, hydrindanone 53a can
be obtained in 58% isolated yield with >20:1 dr for the trans-fused ring system. The corre-
sponding four-membered fused ring system 52a was not observed. The selective formation of
trans-fused diastereomer can be explained when taking a look at the mechanism(Figure 2.10).
Ph
O CoCl2 10 mol%dppe 10 mol%
act. Zn 20 mol%
MeCN
60 °C
2 h
H
O
Ph
58%
Ph
+
Me O
not observed
45a 53a 52a
Figure 2.9. Initial hit
In analogy to our previous chemistry, we propose the initial reduction of CoII to Co0 followed
by oxidative addition into the aldehyde C–H bond of the cyclohexenal 53a to form cobalt
acylhydride intermediate 57. Insertion of the oleﬁn into the cobalt-hydride bond will from
the acyl cobaltacycle 58. This step is inherently trans-selective, since the face from which
the hydride migrates is dictated by the acyl group as shown in Figure 2.10. Reductive
elimination of acyl cobaltacycle 58 will then from the ﬁnal hydrindanone product 53.
With this initial hit in hand, the reaction conditions were optimized by ﬁrst looking at
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Figure 2.10. Proposed reaction mechanism
diﬀerent CoII precatalysts (Table 2.3). There is an increase in reactivity moving in the CoII-
halide series from CoF2 to CoI2, with CoI2 showing the best reactivity. Interestingly, when
using Co(OAc)2 and Co(BF4)2 hexahydrate, isomerization and reduction of the aldehyde are
the predominant pathways. Next, diﬀerent reductants and their eﬀect on the reactivity were
investigated. A range of diﬀerent metals and metal complexes are competent reductants in
this reaction, with Rieke zinc standing out, showing the best reactivity. Hydroacylations on
related motifs have been reported before.145
Table 2.3. Optimization of precatalyst and reductant
Ph
O CoI2 10 mol%dppe 10 mol%
reductant 20 mol%
MeCN
60 °C
2 h
H
O
Ph
Ph
O CoX2 10 mol%dppe 10 mol%
act. Zn 20 mol%
MeCN
60 °C
2 h
H
O
Ph
entry Precatalyst conv. yield
1
2
3
4
5*
6** Co(BF4)2 • 6 H2O
32%
81%
92%
full conv.
72%
92%
13%
58%
68%
73%
-
2%
CoF2
CoCl2
CoBr2
CoI2
Co(OAc)2
* reduction and isomerization observed
** reaction time was 6 h.
entry reductant conv. yield
1
2
4
5
6
31%
72%
n.r.
6%
59%
6%
63%
n.d.
n.d.
53%
Zn dust
ZnEt2
Rieke Co
In
Mn
3 97% 64%Rieke Mg
7 full conv. 73%Rieke Zn
45a 53a 45a 53a
In 2015, our group published the isomerization/hydroacylation of 2-allyl-4-pentenal deriva-
tives using a RhI/III catalytic system.57 We proposed a mechanism similar to the cobalt
catalyzed hydroacylation. When using the conditions from the rhodium catalyzed hydroa-
cylation with 45a, no reaction was observed (see SI). In 2000 Tanaka reported the hydroa-
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cylation of 4-methyl-3-(prop-1-en-2-yl)pent-4-enal, which are closely related to cyclohexenal
45.145 Yet, when employing his conditions using again a rhodium catalyst system, no reaction
was observed. Interestingly, the developed cobalt catalyst is complementary to previously
developed catalyst systems and expands the general substrate scope of intramolecular hy-
droacylations.
Table 2.4. Enantioselective conditions
Ph
O CoI2 10 mol%Ligand 10 mol%
act. Zn 20 mol%
MeCN
60 °C
6 h
H
O
Ph
Ph2P PPh2
Me
ProPhos
P PPh
Ar
Ar
Ph
DIPAMP
Ph2P PPh2
MeMe
ChiraPhos
P P
R
RR
R
DuPhos
P P
t-Bu t-Bu
H H
DuanPhos
PPh2
PPh2
NorPhos
P P
R
RR
R
BPE
N
N P
P
Me
t-Bu
t-Bu
Me
QuinoxP*
entry ligand conv. yield
1
2
4**
5
6**
7** (S,S,R,R)-DuanPhos
full conv.
n.r.
full conv.
full conv.
full conv.
full conv.
79%
n.d.
46%
79%
46%
46%
dppe
dppf
(R,R)-DIPAMP
(S,S)-BDPP
(R,R)-i-Pr-DuPhos
* 34% conv., 8% yield, 39% ee at 40 °C after 6 h.
** Aldehyde prepared through DMP oxidation and presumably of low purity
*** with 10 mol% AgPF
6
ee
n.d.
n.d.
12%
19%
22%
24%
8**
9*
10**
11** (S,S)-Ph-BPE
full conv.
full conv.
full conv.
full conv.
46%
99%
46%
46%
(S,S)-NorPhos
(S,S)-ChiraPhos
(S,S)-i-Pr-BPE
33%
43%
46%
51%
12** full conv. 46%(S,S)-QuinoxP* 56%
3 32% 29%(R)-ProPhos n.d.
13*** full conv. 99%(R,R)-JoSPOphos 99%
FeP
P
Me
Ph
Ph
O
H
t-Bu
JoSPOphos
45a 53a
A variety of chiral bidentate phosphine ligands have been tested to render this transforma-
tion enantioselective. Based on previously reported cobalt catalyzed hydroacylations and
experience from our group.64,118,146–150 We initially focused on chiral bidentate bis-phosphine
ligands. Given that we saw good reactivity with dppe, an achiral bidentate bis-phosphine
ligand, we initially focused on chiral ligands, that have a ethane linkage between the phos-
phines. Interestingly, (R)-ProPhos is structurally very similar so dppe, yet when employing
this ligand in the reaction, we saw dampened reactivity. On the other (S,S )-ChiraPhos,
which bears an extra methyl group in the ethane backbone, shows excellent reactivity and
a promising enantioselectivty of 43% ee. Only (S,S )-QuinoxP* was able to give a higher
selectivity of 56% ee. JoSPOphos proved to be the best ligand for this transformation giving
39
both, high reactivity as well as selectivity.
2.2.3 Conclusion and Future Work
Future studies will focus on the substrate evaluation. Furthermore, an interesting applica-
tion could involve the total synthesis of seiricardine A 63 (Figure 2.11).142 This molecule is
a sesquiterpinoid natural product, that shows phytotoxic activity and has never been syn-
thesized before.151 Starting from hydrindanone 53b, allylic oxidation and hydrogenation of
the oleﬁn would give alcohol 60. Formation of the enol triﬂate, followed by reduction would
give alkene 61. The isopropenyl group can be introduced through a sequence of epoxidation
and epoxide ring opening to gibe ketone 62. Finally, oleﬁnation of the ketone, followed by
subsequent epoxidation and epoxide ring opening would furnish seiricardine A 63.
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OH
Me
H
Me
Me
Me
HO
Me
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H
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1. allylic oxidation
2. hydrogenation
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H
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H
O
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Me
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2. epoxidation
3. isopropenyl-MgBr
Me
Me
H
OH
Me
Me
HO
1. methylenation
2. epoxidation
3. epoxide opening
53b 60 61
62636353b
Figure 2.11. Proposed total synthesis of Seiricardine A
2.3 Experimental Data
The details of the studies described in this chapter can be found in the Supporting Infor-
mation of the published manuscript.118 My contributions to the project are detailed in this
section.
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2.3.1 Experimental Details for Enantioselective Cyclobutatone Syn-
thesis
Evaluation of Cobalt Catalysts
The evaluation of cobalt catalysts was done together with Daniel K. Kim.
Con-catalyst reductant yield (5a) selectivity
(PPh3)3CoICl (5 mol%)
+ BDPP (5 mol%) none 0%
rr n.d.
dr n.d.
(PPh3)3CoICl (5 mol%)
+ BDPP (5 mol%) Zn (10 mol%)
5%
ee n.d.
6:1 rr
>20:1 dr
(PMe3)4Co0 (5 mol%) none 10%ee n.d.
1:1 rr 
1:1 dr
(BDPP)CoIICl2 (10 mol%) Et2Zn (50 mol%) 89%93% ee
10:1 rr 
10:1 dr
(BDPP)CoIICl2 (2 mol%) Zn (10 mol%) 93%93% ee
>20:1 rr 
>20:1 dr
H
O
Ph
O
Me
PhCon-catalyst
MeCN, 50 °C, 24 h
O
Ph
+
19a 24a 31a
Evaluation of Ligands
The evaluation of ligands was done together with Daniel K. Kim.
All cobalt-catalyzed reactions were set up inside of a nitrogen-ﬁlled glovebox. To a 1-dram
vial was added a stirbar and CoCl2 (0.002 mmol, 2 mol%) and ligand (0.002 mmol, 2 mol%)
in MeCN (0.50 mL, 0.2 M). The catalyst mixture was stirred for 5 minutes at room tem-
perature. To the catalyst mixture was added aldehyde 19a (20.0 mg, 0.10 mmol, 1 equiv),
followed by the addition of the indicated amount of activated zinc (0.006 mmol, 6 mol%).
The heterogeneous mixture was sealed with a Teﬂon-lined screw cap and heated the indi-
cated temperature and time. Note: While heating the reaction mixture, the blue mixture
turns green and then yellow before ﬁnally turning dark brown in color over 15–30 minutes.
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Chemo- and regioselectivity were determined from analysis of the reaction mixture by GC-
FID analysis. Yields and selectivies were determined by GC-FID using a standard curve.
Enantiomeric excess were not determined.
Ph H
O
CoCl2 (2 mol%)
Ligand (2 mol%)
activated Zn (6 mol%)
MeCN, 50 °C, 24 h
absolute configuration unknown
Ph
Me
O O
Ph
+
19a 24a 31a
entry ligand conv. yield
1
2
4
5
6
5%
99%
68%
12%
70%
0%
88%
3%
0%
2%
dppm
dppe
dppf
PPh3 (4 mol%)
(R,R)-i-Pr-BPE
3 85% 40%dppp
7 78% 10%
(R,R)-i-Pr-DuPhos8 64% 5%
(S,S)-BenzP*
dr rr
n.d.
>20:1
n.d.
n.d.
10:1
n.d.
>20:1
1:1
n.d.
2:1
10:1 2:1
4:1 1:8
2:1 1:22
9
10
12
13
14
57%
12%
20%
20%
40%
10%
5%
16%
17%
5%
(R)-Binap
JosiPhos (SL-J008-1)
(S)-ProPhos
(R)-Ph-MeOBIPHEP
(S,S)-Ph-MeOBIPHEP
11 89% 70%
(S,S)-ChiraPhos
15 99% 96%
dppb
15:1
n.d.
>20:1
>20:1
>20:1
1:7
1:1
2:1
2:1
1:11
11:1 8:1
>20:1 >20:1
Synthesis of Activated Zinc (Modified Synthesis for Rieke Zinc)
In a 250 mL schlenk ﬂask was added zinc chloride (3.0 g, 22.01 mmol, 1 equiv) and 1 mL
of thionyl chloride to dry the zinc chloride. The mixture was heated under vacuum with a
bunsen burner until zinc chloride melted. The salt was allowed to cool to room temperature
under nitrogen gas. To the cooled mixture was added THF (70.5 mL, 0.31 M) to form a
colorless solution. In a separate 500 mL schlenk ﬂask was added a stirbar, benzo[b]thiophene
(0.107 g, 0.800 mmol, 3.6 mol%), naphthalene (5.77 g, 45.0 mmol, 2.04 equiv), and lithium
metal (0.306 g, 44.0 mmol, 2 equiv) in THF (70.5 mL, 0.62 M) to give a colorless suspension.
To help the lithium dissolve, the mixture was sonicated for 3 minutes. During this time the
solution turned dark green, indicative of lithium naphthalide formation. The zinc cloride
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solution was transfered via cannula addition. The pressure was adjusted o allow for dropwise
addition of zinc chloride into the lithium naphthalide solution. The reaction was stirred for 1
hour. After 1 hour, the stirring was stopped to allow a black solid settle to the bottom of the
ﬂask. Most of the solvent was then removed via cannula transfer and discarded after careful
quenching. Fresh THF (20 mL) was added to the black solid and stirred vigorously for a few
minutes. After vigorous mixing, the stirring was stopped to allow the black solid to settle
at the bottom and most of the solvent removed via cannula transfer. This procedure was
repeated three more times to remove most of the lithium naphthalide and benzo[b]thiophene.
Finally, the residual THF was removed in vacuo. A black shiny solid was isolated (608 mg,
46% yield) and stored in a nitrogen-rich glovebox. Any unreacted lithium pellets that were
still present were removed and quenched.
2-allyl-2-phenylcyclopentan-1-one 31a
O
Ph
Inside a nitrogen-ﬁlled glovebox, to a 100 ml round-bottom ﬂask was
added a stirbar and Co[(S,S )-BDPP)]Cl2(30 mg, 0.3 mmol, 3 mol%)
in MeCN. The catalyst mixture was stirred for 5 minutes at room
temperature. To the catalyst mixture was added aldehyde 19n (2 g,
10 mmol, 1 equiv) and activated zinc (98 mg, 1.5 mmol, 15 mol%). The
heterogeneous mixture was heated to 60 ◦C for 24 h. The selectivities
were determined by GC-FID and 1H NMR analysis (20 second relaxation delay). The crude
reaction was ﬁltered through a 10 ml syringe ﬁlled with silica and eluted with dietyhlether.
The pure ketone 24n was isolated by column chromatography (1.5% EtOAc/Hexanes) in 46
mg as a colorless oil, 2% yield.
1
H-NMR: δ (500 MHz, CDCl3) 7.43 – 7.38 (m, 2H), 7.36
– 7.30 (m, 2H), 7.29 – 7.14 (m, 1H), 5.58 – 5.43 (m, 1H), 5.03 – 4.93 (m, 2H), 2.64 – 2.50
(m, 2H), 2.48 – 2.40 (m, 1H), 2.37 – 2.20 (m, 2H), 2.15 – 2.04 (m, 1H), 1.99 – 1.89 (m,
1H), 1.89 – 1.77 (m, 1H).
13
C-NMR: δ (126 MHz, CDCl3) 219.28, 139.69, 134.12, 128.65,
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126.97, 126.95, 118.15, 56.62, 43.44, 37.81, 33.38, 18.69. HRMS (ESI-TOF) m/z calculated
for C14H16O [M+Na]
+: 223.1099, found 223.1098. IR (ATR): 2963, 1732, 1495, 1445, 1153,
1001, 916, 754, 698 cm−1. [α]25D +245.0
◦ (c=0.05, CHCl3).
2-allyl-2-(thiophen-3-yl)pent-4-en-1-ol
OH
S
In a round-bottom ﬂask was a THF (0.2 M) solution of methyl 2-
(thiophen-3-yl)acetate (1 equiv) in an acetone/dry ice bath at –78 ◦C.
Sodium bis(trimethylsilyl)amide (NaHMDS) in THF (2.5 equiv) was
added. The solution was stirred for 30 minutes. Then, allyl bromide
(2.5 equiv) was added dropwise to the reaction mixture. The solution
was warmed to room temperature and stirred for 1–4 hours, monitoring by TLC. The reaction
mixture was quenched with aqueous NH4Cl solution and washed with aqueous 2 M HCl
solution(to remove amine salts). The aqueous layer was extracted with ethyl acetate three
times. The organic layers were combined and dried over Na2SO4,ﬁltered, and concentrated.
The resulting dienylester was used without further puriﬁcation. LiAlH4 (2.5 equiv) was
added slowly to a stirring solution of dienylester (1 equiv) in 25 mL THF (0.2 M) in a ◦C
ice/water bath. After addition of LiAlH4, the ice bath was removed and the reaction mixture
was allowed to stir at room temperature for 20 minutes to 4 hours, monitoring by TLC. The
reaction mixture was quenched by careful dropwise addition of 1 M HCl solution at 0 ◦C.The
mixture was separated by separatory funnel and the aqueous layer was extracted three times
with ethyl acetate. The organic layer was dried over Na2SO4,ﬁltered, and concentrated.
The resulting alcohol was then puriﬁed by ﬂash column chromatography, giving 1.03 g as a
colorless oil, 77% yield.
1
H-NMR: δ (499 MHz, CDCl3) 7.33 (dd, J = 5.0, 2.9 Hz, 1H), 7.12
– 6.95 (m, 2H), 5.67 (ddt, J = 17.3, 10.1, 7.3 Hz, 2H), 5.15 – 4.93 (m, 4H), 3.71 (s, 2H),
2.47 (qd, J = 13.9, 7.3 Hz, 4H), 1.36 (s, 1H).
13
C-NMR: δ (126 MHz, CDCl3) 145.44, 134.28,
126.37, 125.86, 121.14, 118.13, 68.14, 45.17, 39.81. HRMS (ESI-TOF) m/z calculated for
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C12H16OS [M+Na]
+: 231.0820, found 231.0827. IR (ATR): 3408, 3073, 2923, 1638, 1047,
912, 780 cm−1.
2-allyl-2-(thiophen-3-yl)pent-4-enal (19n)
H
S O
To a round-bottom ﬂask was added dropwise dimethylsulfoxide
(DMSO)(3 equiv) to a solution of oxalyl chloride (1.3 equiv) in DCM
(0.2 M) at –78 ◦C in an acetone/dry ice bath, and then stirred for 30
minutes. A solution of dienylalcohol (1 equiv) in DCM was added drop-
wise at –78 ◦C and stirred for 30 minutes. After stirring the reaction
for 30 minutes, triethylamine (5 equiv) was added dropwise at –78 ◦C. The reaction mix-
ture was then warmed to room temperature and stirred for an additional 30 minutes. The
reaction was quenched with water and extracted with DCM. The organic layer was washed
with water, dried over Na2SO4, ﬁltered, and concentrated in vacuo. The crude residue was
puriﬁed by silica gel column chromatography, giving 360 mg of 19n) as a colorless oil, 48%
yield.
1
H-NMR: δ (500 MHz, CDCl3) 9.50 (s, 1H), 7.40 – 7.30 (m, 1H), 7.20 – 7.05 (m, 1H),
7.04 – 6.83 (m, 1H), 5.58 (dq, J = 17.2, 8.7, 8.1 Hz, 2H), 5.25 – 4.62 (m, 4H), 2.70 (d, J =
7.3 Hz, 4H).
13
C-NMR: δ (126 MHz, CDCl3) 201.11, 139.50, 132.70, 126.72, 126.51, 122.69,
119.10, 55.30, 37.18. HRMS (ESI-TOF) m/z calculated for C23H14OS [M+Na]
+: 224.1109,
found 224.1110. IR (ATR): 3077, 2978, 2917, 2805, 2710, 1722, 1441, 994, 916, 862, 778, 664
cm−1.
(2R,4R)-2-allyl-4-methyl-2-(thiophen-3-yl)cyclobutan-1-one (24n)
O
Me
S
Inside a nitrogen-ﬁlled glovebox, to a 1-dram vial was added a stirbar
and Co[(S,S )-BDPP)]Cl2(1.1 mg, 0.002 mmol, 2 mol%) in MeCN. The
catalyst mixture was stirred for 5 minutes at room temperature. To
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the catalyst mixture was added aldehyde 19n (20.6 mg, 0.1 mmol,
1 equiv) and activated zinc (0.6 – 0.7 mg, 0.010 mmol, 10 mol%). The
heterogeneous mixture was sealed with a Teﬂon-lined screw cap and
heated to 50 ◦C for 24 h. The selectivities were determined by GC-FID and 1H NMR
analysis (20 second relaxation delay). The pure ketone 24n was isolated by preparative
TLC (10% EtOAc/Hexanes) as a colorless oil (18.9 mg,92% isolated yield, 83% ee, 11:1 dr,
12:1 rr).
1
H-NMR: δ (499 MHz, CDCl3) 7.31 – 7.27 (m, 1H), 7.15 – 7.12 (m, 1H), 7.09 – 7.00
(m, 1H), 5.63 (ddt, J = 17.3, 10.4, 7.2 Hz, 1H), 5.33 – 4.90 (m, 2H), 3.48 – 3.25 (m, 1H),
2.66 – 2.44 (m, 3H), 1.93 (dd, J = 11.3, 7.6 Hz, 1H), 1.17 (d, J = 7.4 Hz, 3H).
13
C-NMR:
δ (500 MHz CRYO, CDCl3) 213.73, 141.64, 133.19, 126.27, 125.87, 120.24, 118.81, 66.48,
50.19, 42.86, 31.81, 14.50. IR(ATR): 2965, 1769, 1373, 991, 919, 784, 645 cm−1. HRMS
(ESI-TOF) m/z calculated for C12H14OS [M+Na]
+: 229.0663, found 229.0673. Chiral SFC
(Regis Technologies, Whelk-O column, 220 nm, 2% 2-propanol in CO2, 2.0 mL/min, 30
◦C):
3.19 minutes, 3.61 minutes (back peak is major enantiomer).
(1S,2R,4R)-2-allyl-4-methyl-2-phenylcyclobutan-1-ol (37)
OH
Me
Ph
To a vial equipped with a stir bar was added ketone 24a (25 mg,
0.13 mmol ) and Diisobutylaluminium hydride (137 μl, 1M in THF,
0.14 mmol) in THF (0.3 ml). The reaction was stirred at 0 ◦C for 1 h.
A few drops of AcOH were added until gas evolution stopped. 3 ml of
sat. NH4Cl (aq) were added and the layers separated. The aq. layer extracted with 2 ml of
EtOAc three times. The organic phase was washed with 5 ml of sat. NaCl (aq), dried over
MgSO4, ﬁltered, and concentrated under reduced pressure. The unpuriﬁed reaction mixture
was then puriﬁed by PTLC (10% EtOAc/Hexanes) to aﬀord 25 mg of (37) as a colorless
oil, 80% yield, 15:1 dr.
1
H-NMR: δ (499 MHz, CDCl3) 7.34 – 7.24 (m, 2H), 7.24 – 7.13
(m, 3H), 5.82 – 5.44 (m, 1H), 5.35 – 4.61 (m, 2H), 3.92 (d, J = 7.8 Hz, 1H), 2.63 – 2.45
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(m, 2H), 2.40 – 2.27 (m, 1H), 2.26 – 2.16 (m, 1H), 2.09 (s, 1H), 1.41 (t, J = 10.3 Hz, 1H),
1.13 (d, J = 6.5 Hz, 3H).
13
C-NMR: δ (126 MHz, CDCl3) 149.37, 135.17, 128.19, 126.00,
125.86, 117.35, 81.91, 50.03, 40.26, 37.05, 30.96, 18.77. HRMS (ESI-TOF) m/z calculated
for C14H18O [M+Na]
+: 225.1255, found 225.1263. IR (ATR): 3332, 2951, 1445, 1071, 1071,
912, 701 cm−1. [α]25D +30.6
◦ (c=0.75, CHCl3).
(1R,2R,4R)-2-allyl-4-methyl-2-phenylcyclobutan-1-ol (38)
OH
Me
Ph
To a vial equipped with a stir bar was added ketone 24a (10 mg,
0.05 mmol) and L-Selectride (55 μl, 1M in THF, 0.06 mmol) in THF
(0.3 ml). The reaction was stirred at 0 ◦C for 1 h. A few drops of AcOH
were added until gas evolution stopped. 3 ml of sat. NH4Cl (aq) were
added and the layers separated. The aq. layer extracted with 2 ml of EtOAc three times.
The organic phase was washed with 5 ml of sat. NaCl (aq), dried over MgSO4, ﬁltered, and
concentrated under reduced pressure. The unpuriﬁed reaction mixture was then puriﬁed by
PTLC (10% EtOAc/Hexanes) to aﬀord 10 mg of 38 as a colorless oil, 81% yield, >20:1 dr.
1
H-NMR: δ (500 MHz, CDCl3) 7.39 – 7.30 (m, 2H), 7.24 – 7.18 (m, 1H), 7.17 – 7.11 (m,
2H), 5.55 – 5.29 (m, 1H), 5.05 – 4.77 (m, 2H), 4.22 (s, 1H), 2.80 – 2.58 (m, 1H), 2.58 –
2.38 (m, 2H), 2.30 – 2.16 (m, 1H), 2.16 – 2.04 (m, 1H), 1.34 (s, 1H), 0.98 (d, J = 7.1 Hz,
3H).
13
C-NMR: δ (126 MHz, CDCl3) 142.68, 134.57, 128.47, 127.83, 126.24, 117.40, 76.16,
50.03, 46.42, 33.75, 29.66, 13.94. HRMS (ESI-TOF) m/z calculated for C14H18O [M+Na]
+:
255.1255, found 225.1261. IR (ATR): 3426, 2925, 1444, 1104, 989, 912, 767, 701 cm−1. [α]25D
–5.53◦ (c=0.041, CHCl3).
(R)-4-allyl-2-methyl-4-phenylcyclobut-1-en-1-yl trifluoromethanesulfonate (39)
47
OTf
Me
Ph In a 100 ml schlenk ﬂask equipped with a stir bar was LiHMDS (134 mg,
0.80 mmol) in THF (1.5 ml) to give a yellow solution. Ketone 24a
(100 mg, 0.50 mmol) in THF (1.5 ml) was added to the LiHMDS so-
lution and the resulting reaction mixture cooled to –30 ◦C. Comin’s
reagent in THF (1.5 ml) was added to the reaction and stirred at rt for 2 h. 3 ml of sat.
NaCl (aq) and 3 ml of EtOAc were added to the reaction and the layers separated in a
separatory funnel. The organic phase was washed with 5 ml of sat. NaCl (aq), dried over
MgSO4, ﬁltered, and concentrated under reduced pressure. The unpuriﬁed reaction mixture
was then puriﬁed by column chromatography (0.5% EtOAc and 0.5% Et3N in Hexanes) to
aﬀord 50 mg of 39 as a colorless oil, 30% yield.
1
H-NMR: δ (500 MHz, CDCl3) 7.45 –
7.06 (m, 5H), 5.68 (ddt, J = 17.1, 10.0, 7.1 Hz, 1H), 5.27 – 4.87 (m, 2H), 2.64 (d, J =
7.2 Hz, 2H), 2.37 (q, J = 11.0 Hz, 2H), 1.80 (s, 3H).
13
C-NMR: δ (126 MHz, CDCl3) 143.29,
142.01, 135.87, 133.80, 128.49, 127.34, 126.93, 126.64, 118.39, 56.81, 42.22, 38.57, 12.62.
HRMS (ESI-TOF) m/z calculated for C15H15F3O3S [M+Na]
+: 355.0592, found 355.0604.
IR (ATR): 2922, 1417, 1208, 1139, 1063, 857, 697, 611 cm−1. [α]25D +27.8
◦ (c=0.3, CHCl3).
(1S,2R,4R)-2-allyl-4-methyl-1,2-diphenylcyclobutan-1-ol (42)
OH
Me
Ph
Ph
In a 50 ml schlenk tube equipped with a stir bar was ketone 24a
(100 mg, 0.5 mmol) in THF (2.5 ml) to give a colorless solution. Phenyl-
magnesium bromide (0.37 ml, 2.71 M in THF, 1 mmol) was added to
the reaction at 0 ◦C. The reaction was stirred at rt fo 2 h. 3 ml of sat.
KHSO4 (aq) was added and the reaction mixture transferred to a separatory funnel. The
layers were separated and the aq. layer extracted with 5 ml of EtOAc three times. The
organic phase was washed with 5 ml of sat. KHSO4 (aq), 5 ml of sat. NaCl (aq), dried over
MgSO4, ﬁltered, and concentrated under reduced pressure. The unpuriﬁed reaction mixture
was then puriﬁed by column chromatography (5% EtOAc in Hexanes) to aﬀord 126 mg of
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42 as a colorless oil, 91% yield >20:1 dr.
1
H-NMR: δ (499 MHz, CDCl3) 7.69 – 7.57 (m,
2H), 7.53 – 7.37 (m, 5H), 7.36 – 7.25 (m, 3H), 5.31 – 5.14 (m, 1H), 5.00 – 4.84 (m, 2H), 3.34
(dq, J = 15.9, 8.3, 7.2 Hz, 1H), 2.47 (dd, J = 13.8, 8.1 Hz, 1H), 2.43 – 2.33 (m, 1H), 2.33 –
2.24 (m, 1H), 2.10 (dd, J = 13.7, 5.4 Hz, 1H), 1.92 (s, 1H), 1.15 (d, J = 6.8 Hz, 3H).
13
C-
NMR: δ (126 MHz, CDCl3) 142.34, 141.96, 134.81, 128.47, 128.27, 127.91, 127.47, 126.94,
126.70, 117.22, 82.52, 53.71, 42.98, 31.79, 31.61, 12.86. HRMS (ESI-TOF) m/z calculated
for C20H22O [M+Na]
+: 301.1568, found 301.1563. IR (ATR): 3560, 2924, 1494, 1444, 1278,
992, 912, 696 cm−1. [α]25D –31.9
◦ (c=0.3, CHCl3).
(1R,2R,4R)-2-allyl-4-methyl-2-phenyl-1-vinylcyclobutan-1-ol (41)
OH
Me
Ph
In a 100 ml schlenk ﬂask equipped with a stir bar was ketone 24a
(200 mg, 1.0 mmol) in THF (5 ml) to give a colorless solution. Vinyl-
magnesium bromide (12.48 ml, 0.36 M in THF, 4.5 mmol) was added
to the reaction at 0 ◦C. The reaction was stirred at rt for 2 h. 5 ml
of sat. KHSO4 (aq) was added and the reaction mixture transferred to a separatory funnel.
The layers were separated and the aq. layer extracted with 5 ml of EtOAc three times. The
organic phase was washed with 5 ml of sat. KHSO4 (aq), 5 ml of sat. NaCl (aq), dried over
MgSO4, ﬁltered, and concentrated under reduced pressure. The unpuriﬁed reaction mixture
was then puriﬁed by column chromatography (3% EtOAc in hexanes) to aﬀord 159 mg of
(41) as a colorless oil, 70% yield >20:1 dr.
1
H-NMR: δ (499 MHz, CDCl3) 7.37 – 7.30 (m,
2H), 7.24 – 7.18 (m, 1H), 7.10 – 7.00 (m, 2H), 6.20 (dd, J = 17.3, 11.1 Hz, 1H), 5.43 – 5.20
(m, 3H), 4.96 – 4.83 (m, 2H), 2.70 – 2.61 (m, 1H), 2.59 – 2.51 (m, 1H), 2.51 – 2.42 (m, 1H),
2.23 – 2.15 (m, 1H), 2.15 – 2.05 (m, 1H), 1.35 (s, 1H), 0.99 (d, J = 6.8 Hz, 3H).
13
C-NMR:
δ (126 MHz, CDCl3) 143.01, 140.24, 134.86, 128.59, 127.08, 126.51, 117.38, 114.94, 80.80,
53.17, 43.52, 33.61, 32.60, 12.69. HRMS (ESI-TOF) m/z calculated for C16H20O [M+Na]
+:
251.1412, found 251.1405. IR (ATR): 3565, 2975, 2926, 1445, 979, 912, 700 cm−1. [α]25D
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–12.45◦ (c=0.4, CHCl3).
(1S,2R,4R)-2-allyl-4-methyl-2-phenyl-1-(prop-1-en-2-yl)cyclobutan-1-ol
OH
Me
Ph Me
In a 25 ml schlenk tube equipped with a stir bar was ketone 24a
(100 mg, 0.50 mmol) in THF (2.5 ml) to give a colorless solution.
Isopropenyl magnesium bromide (2 ml, 0.5 M in THF, 1 mmol) was
added to the reaction at 0 ◦C. The reaction was stirred at rt for 2 h.
5 ml of sat. KHSO4 (aq) was added and the reaction mixture transferred to a separatory
funnel. The layers were separated and the aq. layer extracted with 5 ml of EtOAc three
times. The organic phase was washed with 5 ml of sat. KHSO4 (aq), 5 ml of sat. NaCl
(aq), dried over MgSO4, ﬁltered, and concentrated under reduced pressure. The unpuriﬁed
reaction mixture was then puriﬁed by column chromatography (5% EtOAc in hexanes) to
aﬀord 90 mg as a colorless oil, 74% yield >20:1 dr.
1
H-NMR: δ (499 MHz, CDCl3) 7.40 –
7.33 (m, 2H), 7.32 – 7.28 (m, 2H), 7.28 – 7.21 (m, 1H), 5.36 – 5.24 (m, 1H), 5.11 (s, 1H), 5.06
(s, 1H), 4.97 – 4.81 (m, 2H), 2.98 – 2.81 (m, 1H), 2.59 – 2.51 (m, 1H), 2.50 – 2.41 (m, 1H),
2.19 – 2.11 (m, 1H), 2.11 — 2.03 (m, 1H), 1.89 (s, 3H), 1.45 (s, 1H), 1.03 (d, J = 6.8 Hz,
3H).
13
C-NMR: δ (126 MHz, CDCl3) 146.03, 141.42, 135.01, 128.43, 128.40, 126.64, 117.29,
114.08, 83.32, 53.46, 41.57, 31.81, 30.88, 20.42, 13.00. HRMS (ESI-TOF) m/z calculated
for C17H22O [M+Na]
+: 265.1568, found 265.1557. IR (ATR): 3568, 2974, 1773, 1638, 1445,
1127, 984, 901, 699 cm−1. [α]25D –29.7 (c=0.4, CHCl3).
(2R,3R,5R)-3-allyl-2-(bromomethyl)-2,5-dimethyl-3-phenylcyclopentan-1-one (43)
O
Me
Ph
Me Br
In a 25 ml schlenk tube equipped with a stirbar was N -
bromosuccinimide (99 mg, 0.56 mmol) in THF (4.6 ml) to give a yel-
low solution. The previously prepared alcohol (90 mg, 0.37 mmol) was
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added to the reaction at 0 ◦C. The reaction was stirred at 0 ◦C for
4 h. 5 ml of sat. NaHCO3 (aq) was added and the reaction mixture
transferred to a separatory funnel. The layers were separated and the aq. layer extracted
with 5 ml of EtOAc three times. The organic phase was washed with 5 ml of sat. NaCl
(aq), dried over MgSO4, ﬁltered, and concentrated under reduced pressure. The unpuriﬁed
reaction mixture was then puriﬁed by column chromatography (5% EtOAc in hexanes) to
aﬀord 72 mg of 43 as a colorless oil, 60% yield >20:1 dr.
1
H-NMR: δ (500 MHz, CDCl3)
7.49 – 7.41 (m, 2H), 7.39 – 7.30 (m, 2H), 7.30 – 7.21 (m, 1H), 5.39 – 5.24 (m, 1H), 5.09 –
4.89 (m, 2H), 3.80 (d, J = 11.3 Hz, 1H), 3.69 (d, J = 11.3 Hz, 1H), 3.11 – 3.01 (m, 1H),
2.48 – 2.40 (m, 1H), 2.40 – 2.33 (m, 1H), 2.29 (dd, J = 14.3, 9.3 Hz, 1H), 2.17 – 2.06 (m,
1H), 1.26 (d, J = 6.9 Hz, 3H), 0.78 (s, 3H).
13
C-NMR: δ (126 MHz, CDCl3) 220.21, 141.06,
134.40, 128.26, 128.19, 126.94, 118.03, 56.21, 51.49, 40.09, 39.96, 35.35, 34.62, 21.95, 16.24.
HRMS (ESI-TOF) m/z calculated for C17H21BrO [M+Na]
+: 343.0674 and 345.0655, found
343.0670 and 345.0654. IR (ATR): 2970, 1735, 1445, 1372, 1295, 1255, 993, 915, 697 cm−1.
[α]25D –44.9
◦ (c=0.3, CHCl3).
(1R,2R,4R)-2-allyl-1,4-dimethyl-2-phenylcyclobutan-1-ol
OH
Me
Ph
Me
In a 25 ml schlenk tube equipped with a stir bar was ketone 24a
(100 mg, 0.50 mmol) in THF (2.5 ml) to give a colorless solution.
Methylmagnesium bromide (0.3 ml, 3 M in THF, 1 mmol) was added
to the reaction at 0 ◦C. The reaction was stirred at 0 ◦C for 1 h. 5 ml
of sat. KHSO4 (aq) was added and the reaction mixture transferred to a separatory funnel.
The layers were separated and the aq. layer extracted with 5 ml of EtOAc three times. The
organic phase was washed with 5 ml of sat. NaCl (aq), dried over MgSO4, ﬁltered, and
concentrated under reduced pressure. The unpuriﬁed reaction mixture was then puriﬁed
by column chromatography (5% EtOAc in hexanes) to aﬀord 34 mg as a colorless oil, 32%
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yield >20:1 dr.
1
H-NMR: δ (500 MHz, CDCl3) 7.38 – 7.30 (m, 2H), 7.24 – 7.20 (m, 1H),
7.15 – 7.05 (m, 2H), 5.39 – 5.25 (m, 1H), 5.05 – 4.81 (m, 2H), 2.61 – 2.53 (m, 1H), 2.53 –
2.45 (m, 1H), 2.41 – 2.31 (m, 1H), 2.17 (dd, J = 10.9, 8.1 Hz, 1H), 2.11 – 2.01 (m, 1H),
1.39 (s, 3H), 1.32 (s, 1H), 0.99 (d, J = 6.8 Hz, 3H).
13
C-NMR: δ (126 MHz, CDCl3) 143.32,
135.07, 128.53, 127.35, 126.40, 117.21, 79.39, 52.18, 43.33, 35.07, 33.03, 23.35, 12.80. HRMS
(ESI-TOF) m/z calculated for C15H20O [M+Na]
+: 239.1412, found 239.1413. IR (ATR):
3577, 2924, 1445, 1178, 911, 699 cm−1. [α]25D +6.1 (c=0.5, CHCl3).
(5R,7S,9R)-9-allyl-7-methyl-9-phenyl-1-oxaspiro[4.4]nonan-6-one (44)
O
Me
Ph O
In a 25 ml schlenk tube equipped with a stir bar was 1,2-dihydrofuran
(0.1 ml, 1.50 mmol) in THF (2.5 ml) to give a colorless solution. n-
butyllithium (0.8 ml, 1.6 M in hexane, 1.25 mmol) was added at 0 ◦C.
After 3 h, the reaction was cooled to –78 ◦C and ketone 24a (200 mg
in 2 ml THF, 1.00 mmol) added dropwise. The reaction was quenched
with 5 ml sat. NaHCO3 (aq) after 3 h and the reaction mixture was transferred to a
separatory funnel. The layers were separated and the aq. layer extracted with 5 ml of
EtOAc three times. The organic phase was washed with 5 ml of sat. NaCl (aq), dried over
MgSO4, ﬁltered, and concentrated under reduced pressure. The unpuriﬁed reaction mixture
was then puriﬁed by column chromatography (5% EtOAc in hexanes) to aﬀord 114 mg of
44 as a crystalline solid, 42% yield, 15:1 dr.
1
H-NMR: δ (600 MHz, CDCl3) 7.41 – 7.37 (m,
2H), 7.36 – 7.30 (m, 2H), 7.30 – 7.22 (m, 1H), 5.23 (dtd, J = 17.0, 9.7, 4.8 Hz, 1H), 4.94
– 4.85 (m, 2H), 4.21 (td, J = 7.8, 5.7 Hz, 1H), 4.05 – 3.97 (m, 1H), 2.93 – 2.84 (m, 1H),
2.49 (dd, J = 12.6, 8.7 Hz, 1H), 2.36 (ddt, J = 15.8, 10.6, 7.2 Hz, 1H), 2.13 (dd, J = 14.7,
9.4 Hz, 1H), 1.86 (ddt, J = 15.0, 12.0, 7.7 Hz, 1H), 1.73 (ddd, J = 12.7, 10.9, 1.9 Hz, 1H),
1.62 – 1.53 (m, 1H), 1.50 (ddd, J = 12.8, 7.9, 4.9 Hz, 1H), 1.40 (dt, J = 12.8, 8.0 Hz, 1H),
1.24 (d, J = 7.2 Hz, 3H).
13
C-NMR: δ (151 MHz, CDCl3) 222.17, 142.74, 134.31, 128.32,
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127.29, 126.79, 117.48, 94.34, 70.34, 49.86, 40.49, 36.83, 33.23, 31.38, 25.11, 17.32. HRMS
(ESI-TOF) m/z calculated for C18H22O22 [M+NH4]
+: 288.1964, found 288.1958. IR (ATR):
2974, 2872, 1745, 1448, 1051, 912, 703 cm−1. [α]25D –14.5
◦ (c=0.04, CHCl3).
2.3.2 Experimental Details for Selective Synthesis of trans-Hydrindanones
2-benzylcyclohexane-1,3-dione 7
O O
Ph
In a 500 ml round-botton ﬂask was added cyclohexane-1,3-dione (10 g,
89 mmol), benzaldehyde (27.3 ml, 267 mmol) and Hantzsch ester
(22.5 g, 89 mmol) in DCM (178 ml) to give a white suspension. l-
proline (2.05 g, 1.78 mmol) was added and the reaction stirred for 24 h
at room temperature. The reaction was quenchend by the addition of
2 M HCl (aq), until the pH was around 3. The reaction mixture was transferred to a sep-
aratory funnel. The layers were separated and the aq. layer extracted with 100 ml EtOAc
three times. The organic phase was washed with 200 ml of sat. NaCl (aq), dried over
MgSO4, ﬁltered, and concentrated under reduced pressure. The unpuriﬁed reaction mixture
was then recystallized from EtOAc and a minimum amount of MeOH to aﬀord 16.7 g of 7
as a crystalline solid, 93% yield.
1
H-NMR: δ (500 MHz, CDCl3) 7.15 – 7.03 (m, 4H), 7.01 –
6.95 (m, 1H), 2.30 (t, J = 6.4 Hz, 4H), 1.83 (p, J = 6.4 Hz, 2H).
13
C-NMR: δ (126 MHz,
CDCl3) 141.56, 128.41, 127.85, 125.25, 115.61, 48.82, 27.36, 20.68. HRMS (ESI-TOF) m/z
calculated for C13H14O2 [M+Na]
+: 225.0892, found 225.0888. IR (ATR): 3130.05, 1597.59,
1373.48, 1256.93, 1175.24, 1140.38, 1076.19, 1002.01, 759.00, 720.57, 697.25, 597.20 cm−1.
2-allyl-2-benzylcyclohexane-1,3-dione 8
53
O O
Ph
In a 250 ml round-bottom ﬂask 7 (11.6 g, 57.4 mmol) was added to
a solution of NaOH (115 ml, 1 M in H2O, 115 mmol) at 0
◦C. Allyl
bromide (9.93 ml, 115 mmol) and TBAI (695 mg, 2.87 mmol) were
added. The reaction was stirred for 48 h at room temperature. The
reaction was quenched with 500 ml of sat. NaHCO3 (aq) and the
reaction mixture was transferred to a separatory funnel. The layers were separated and
the aq. layer extracted with 100 ml EtOAc three times. The organic phase was washed
with 200 ml of sat. NaCl (aq), dried over MgSO4, ﬁltered, and concentrated under reduced
pressure. The unpuriﬁed reaction mixture was then puriﬁed by column chromatography
(10% EtOAc in Hexanes) to aﬀord 12.4 g of 8 as a crystalline solid, 89% yield.
1
H-NMR: δ
(600 MHz, CDCl3) 7.24 – 7.14 (m, 3H), 7.03 – 6.92 (m, 2H), 5.57 – 5.46 (m, 1H), 5.08 – 5.00
(m, 2H), 2.64 (d, J = 7.6 Hz, 1H), 2.33 (ddd, J = 16.9, 8.5, 5.1 Hz, 1H), 2.06 (ddd, J =
16.7, 8.3, 5.0 Hz, 1H), 1.69 – 1.56 (m, 1H), 1.15 (ddp, J = 13.7, 9.3, 4.9 Hz, 1H).
13
C-NMR:
δ (151 MHz, CDCl3) 212.24, 136.59, 132.48, 130.00, 128.68, 127.21, 119.70, 69.43, 44.75,
43.06, 41.29, 15.50. HRMS (ESI-TOF) m/z calculated for C16H18O2 [M+Na]
+: 265.1205,
found 265.1208. IR (ATR): 2933.61, 1719.46, 1690.59, 1455.89, 1443.87, 1412.00, 1339.59,
1255.05, 1218.12, 1200.89, 1093.55, 996.18, 929.52, 866.38, 767.23 cm−1.
((1-allyl-2,6-dimethylenecyclohexyl)methyl)benzene (9)
Ph
In a 500 ml schlenk ﬂask was methyltriphenylphosphonium bromide
(28.6 g, 103 mmol) in THF (206 ml) to give a white suspension. Potas-
sium tert-butoxide (7.54 g, 103 mmol) was added to the reaction and
was stirred at room temperature for 30 minutes. A solution of 8 was
added (10 ml, 2 M in THF, 20.63 mmol) and the reaction stirred for
3 h. The reaction was quenched with 200 ml of sat. NaHCO3 (aq) and
the reaction mixture was transferred to a separatory funnel. The layers were separated and
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the aq. layer extracted with 100 ml EtOAc three times. The organic phase was washed
with 200 ml of sat. NaCl (aq), dried over MgSO4, ﬁltered, and concentrated under reduced
pressure. The unpuriﬁed reaction mixture was then puriﬁed by column chromatography
(Hexanes) to aﬀord 4.9 g of 9 as a crystalline solid, 26% yield.
1
H-NMR: δ (500 MHz,
CDCl3) 7.22 (d, J = 7.4 Hz, 3H), 7.12 – 7.05 (m, 2H), 5.06 – 4.93 (m, 2H), 4.90 (s, 2H),
4.56 (s, 2H), 2.92 (s, 2H), 2.53 – 2.37 (m, 4H), 2.38 – 2.27 (m, 2H), 1.87 – 1.73 (m, 1H),
1.59 – 1.46 (m, 1H).
13
C-NMR: δ (126 MHz, CDCl3) 150.52, 138.25, 136.51, 130.92, 127.45,
126.07, 115.97, 111.04, 50.45, 44.85, 39.20, 33.68, 26.80. HRMS (ESI-TOF) m/z calculated
for C18H22 [M]
+: 238.1721, found 238.1726. IR (ATR): 3074.62, 3028.21, 2931.39, 2859.46,
1627.73, 1495.27, 1450.82, 993.02, 894.41, 698.05 cm−1.
3-(1-benzyl-2,6-dimethylenecyclohexyl)propane-1,2-diol (10)
Ph
OH
OH
In a 200 ml round-bottom ﬂask was added 9 (1.1 g, 4.61 mmol) in THF
(42 ml) and H2O (4.20 ml) to give a colorless solution. Osmium tetrox-
ide (1.17 ml, 0.19 mmol) and 4-methylmorpholine N -oxide (649 mg,
5.54 mmol) were added and the reaction stirred at room temperature.
The reaction was quenched after 24 h with 100 ml of sat. NaSO3 (aq)
and stirred for 1 h. 50 ml of sat. NaHCO3 (aq) were added and the reaction mixture was
transferred to a separatory funnel. The layers were separated and the aq. layer extracted
with 100 ml EtOAc three times. The organic phase was washed with 100 ml of sat. NaCl
(aq), dried over MgSO4, ﬁltered, and concentrated under reduced pressure. The unpuriﬁed
reaction mixture was then puriﬁed by column chromatography (40% EtOAc in hexanes) to
aﬀord 472 mg of 10 as a colorless oil, 38% yield.
1
H-NMR: δ (499 MHz, CDCl3) 7.24 – 7.12
(m, 3H), 7.10 – 7.04 (m, 2H), 5.01 (s, 2H), 4.72 (d, J = 9.4 Hz, 2H), 4.00 – 3.90 (m, 1H), 3.54
(dd, J = 11.1, 3.4 Hz, 1H), 3.41 (dd, J = 11.0, 7.6 Hz, 1H), 3.03 – 2.91 (m, 2H), 2.39 – 2.08
(m, 4H), 1.89 (dd, J = 15.0, 8.0 Hz, 1H), 1.75 (dd, J = 15.0, 2.5 Hz, 1H), 1.69 – 1.57 (m,
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2H).
13
C-NMR: δ (151 MHz, CDCl3) 152.49, 152.35, 137.93, 131.12, 127.51, 126.17, 111.65,
111.18, 69.73, 67.48, 49.83, 45.74, 41.21, 33.05, 24.54. HRMS (ESI-TOF) m/z calculated for
C18H24O2 [M+Na]
+: 295.1674, found 195.1683.
2-(1-benzyl-2,6-dimethylenecyclohexyl)acetaldehyde (45a)
Ph CHO
In a 50 ml pear shaped ﬂask was added 10 (472 mg, 1.73 mmol) in
THF (17.4 ml) and water (4.4 ml) to give a colorless solution. Sodium
periodate (741 mg, 3.47 mmol) was added and the reaction stirred for
3 h. The reaction was quenched with 20 ml of sat. NaHCO3 (aq) and
20 ml of sat. NaCl (aq) and the reaction mixture was transferred to a
separatory funnel. The layers were separated and the aq. layer extracted with 20 ml EtOAc
three times. The organic phase was washed with 50 ml of sat. NaCl (aq), dried over MgSO4,
ﬁltered, and concentrated under reduced pressure. The unpuriﬁed reaction mixture was then
puriﬁed by column chromatography (1% EtOAc in hexanes) to aﬀord 309 mg of 45a as a
colorless oil, 74% yield.
1
H-NMR: δ (500 MHz, CDCl3) 9.58 (t, J = 2.1 Hz, 1H), 7.25 –
7.16 (m, 3H), 7.08 – 6.96 (m, 2H), 4.94 (s, 2H), 4.44 (s, 2H), 2.94 (s, 2H), 2.63 (td, J =
14.1, 4.4 Hz, 2H), 2.55 (d, J = 2.3 Hz, 2H), 2.46 (dt, J = 14.3, 3.7 Hz, 2H), 2.03 – 1.79 (m,
1H), 1.66 – 1.43 (m, 1H).
13
C-NMR: δ (126 MHz, CDCl3) 204.36, 150.16, 136.89, 130.69,
127.86, 126.74, 111.51, 48.38, 46.35, 45.54, 33.93, 27.59. HRMS (ESI-TOF) m/z calculated
for C17H20O [M+H]
−: 239.1436, found 239.1445.
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3a-benzyl-7a-methyl-4-methyleneoctahydro-2H -inden-2-one (53a)
Me
O
Ph
Inside a nitrogen-ﬁlled glovebox, to a 1-dram vial was added a stirbar,
CoI2 (0.5 mg, 0.004 mmol, 20 mol%) and dppe (1.6 mg, 0.004 mmol)
in MeCN (104 µl). The catalyst mixture was stirred for 5 minutes
at room temperature. To the catalyst mixture was added aldehyde
45a (5.0 mg, 0.021 mmol, 1 equiv) and activated zinc (0.6 – 0.7 mg,
0.010 mmol, 60 mol%). The heterogeneous mixture was sealed with a Teﬂon-lined screw cap
and heated to 60 ◦C for 24 h. The selectivities were determined by GC-FID and 1H NMR
analysis (20 second relaxation delay). The pure ketone 53a was isolated by preparative TLC
(10% EtOAc/Hexanes) as a colorless oil (3.8 mg,76% isolated yield, >20:1 dr).
1
H-NMR:
δ (600 MHz, CDCl3) 7.24 – 7.14 (m, 3H), 6.97 (d, J = 7.3 Hz, 2H), 4.74 (s, 1H), 4.14 (s,
1H), 3.17 (d, J = 13.1 Hz, 1H), 2.68 (td, J = 14.3, 5.6 Hz, 1H), 2.45 – 2.31 (m, 2H), 2.30
– 2.20 (m, 3H), 2.17 – 1.98 (m, 3H), 1.85 – 1.70 (m, 2H), 1.60 (ddt, J = 18.3, 12.1, 5.7 Hz,
1H).
13
C-NMR: δ (151 MHz, CDCl3) 217.56, 151.10, 137.51, 130.53, 127.91, 126.42, 108.52,
50.31, 48.32, 47.82, 41.06, 34.32, 31.54, 27.88, 23.98. HRMS (ESI-TOF) m/z calculated for
C17H20O [M]
+: 263.1412, found 263.1419. IR (ATR): 2928.38, 2860.80, 1730.72, 1643.80,
1495.78, 1453.55, 1151.54, 1030.15, 892.14, 716.33, 698.86, 603.41 cm−1.
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Chapter 3
Mechanistic DFT-Studies and
In-Silico Catalyst Design
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3.1 Mechanistic DFT Studies of Rh-Catalyzed Cycloi-
somerizations
3.1.1 Introduction
Terpenes are one of the biggest classes of natural products and of great interest to several
disciplines in chemistry and biology.152–154 The diversity of terpenoid natural products stems
from the formation of a common intermediate (i.e. 18), from where diverse terpene scaﬀolds
can be built up.155 Simple precursors like farnesyl pyrophosphate and geranyl pyrophosphate
are cyclized into a variety of natural products .152,156 Their cylization is carried out by a
special class of enzymes, called cyclases.155,157,158
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Figure 3.1. Cycloisomerizations in nature and transition metal catalysis
In the case of geranyl pyrophosphate, all the cycloisomerzation products derive from a com-
mon carbocation intermediate (18). This strategy of product diversiﬁcation from a common
intermediate makes it possible for nature to synthesize a diverse array of natural prod-
ucts through related classes of enzymes (i.e. (+)–α-pinene, (+)–limonene, (+)–camphene,
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Figure 3.1).155 Although there are many mechanistic possibilities from common intermediate
18, cyclases can perform cycloisomerizations to yield one terpinoid product, selectively.159
This selectivity arises from the architecture of the active site, that prefers one transition
state in particular.160
The previously developed transition metal catalyzed cycloisomerization of 19 shows many
parallels to the cycloisomerization of terpenes (Figure 3.1).57,58,118 Also going through a com-
mon intermediate (20), a variety of cycloisomerization products can be obtained. The selec-
tivity is controlled by an ancillary ligand, coordinated to the transition metal. One common
underlying design principle in transition metal catalysis is the use of bulky motifs.161–168 A
rigid ligand geometry oﬀers a deﬁned binding site for a speciﬁc substrate. Steric interactions
between the ligand and the substrate, disfavor undesired pathways. Especially, the 3,5-di-
tert-benzene is a reappearing motif in bidentate phosphine ligands.169–176 This strategy to
achieve speciﬁcity and selectivity would be analogous to the conformational selection model
in enzyme catalysis.
Enzyme Enzyme Enzyme
Enzyme EnzymeEnzyme
k1 k2
k2 k1
conformational selection
induced-fit
Figure 3.2. Conformational selection and induced-ﬁt
Conformational selection and induced-ﬁt are two common theories to explain the speciﬁcity
and selectivity of enzymes.177–180 In the conformational selection theory, the enzyme is in
equilibrium between diﬀerent conformations, where only one will allow the binding of a given
substrate (Figure 3.2). In the induced-ﬁt model, the substrate binds to the enzyme ﬁrst,
which will then undergo a conformational change. Only the correct substrate will undergo
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a reaction after the conformational change of the enzyme. Mismatched substrates dissociate
quickly before being able to undergo a reaction.177 While the conformational selection theory
can account for substrate speciﬁc binding, it can also be used to explain the selectivity in
terpene cyclizations from a common intermediate. The induced-ﬁt mechanism has been
found operative in class I terpene cyclases.181
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Figure 3.3. Ligand controls regiochemical outcome
Although transition metal catalysis is mainly dominated by a lock-and-key type mechanism,
it has been recently suggested that an induced-ﬁt model could also apply to transition metal
catalysis.182 With this study we wanted to investigate if there are other modes that can be
operative in transition metal catalysis, besides the lock-and-key model.183–188
To get a better understanding of the role of bulky motifs in transition metal catalysis, the
cycloisomerization of aldehyde 19 to the cyclohexene 22 and bicycle 21 was studied by
DFT-calculations. Using Ph-SDP (72a) as the ligand, the reaction outcome was a mixture
between 22 and 21 (2:1 rr, Figure 3.3). When using the bulkier DTB-SDP (72b) ligand,
the regioselectivity switched and favored now cyclohexene 22 (>30:1 rr).118
3.1.2 Results and Discussion
We ﬁrst started by elucidating the full mechanistic pathway to identify the turnover limiting
steps for the reactions shown in Figure 3.3. Based on our substrate design, a variety of
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diﬀerent cycloisomerization products are feasible.57,58,118 The full mechanistic pathway in
shown in the SI. Figure 3.4 shows the two pathways that lead to either 21 or 22.
Table 3.1. Experimental and computational agreement
[(coe)2RhCl]2 (1 mol%)
ligand (3 mol%)
NaBArF (3 mol%)
DCE, 40 °C, 4 h
O
H
R
+
Ph-SDP
DTB-SDP
chemoselectivity
R=Phenyl
1:3
1:3
1:3
1:>30O
R
H H
R
O
H
exper. comp.
R=Benzyl
2:1
1:2
2:1
1:23
Ph-SDP
DTB-SDP
exper. comp.
19 21 22
Previous studies on the rhodium catalyzed C–H activation of aldehydes have shown that ini-
tial oxidative addition is followed by oleﬁn insertion into the Rh–H bond to form a rhodacycle
like 20 as an intermediate.69,189–194 From this point, the pending allyl group can intercept
this intermediate, leading to pathways other than hydroacylation (Figure 3.4). Following
the carboacylation pathway (Figure 3.4, right side), carbometalation of the pending oleﬁn
gives bicyclic rhodacycle 70. Further, reductive elimination regenerates the active catalyst
and releases carboacylation product 21. The carbometalation of the other face of the oleﬁn
from rhodacycle 20 leads to the Heck-type pathway (Figure 3.4, left side), giving bicyclic
rhodacycle 65 (Figure 3.4). β-hydride elimination is facile from this intermediate, and leads
to rhodium hydride 67. The aldehyde functional group is being regenerated after reductive
elimination from rhodium hydride 67, releasing cyclohexene product 22. The rate- and
regioselectivity-determining step is the carbometallation shown in transition states 69 and
64 (Figure 3.4).
The proposed catalytic cycle was studied by using the cycloisomerization of 2-benyzl-2-allyl-
4-pentenal and DTB-SDP as the ligand. Further, the cycloisomerization of 2-benzyl-2-allyl-
4-pentenal with Ph-SDP, 2-phenyl-2-allyl-4-pentenal with DTB-SDP and 2-phenyl-2-allyl-4-
pentenal with Ph-SDP as the ligand were used to benchmark our computationally obtained
results against the experimentally observed regioselectivities.58 In all tested cases, we have
found good agreement between the computation and the experiment (Table 3.1).
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Figure 3.4. Ligand controls regiochemical outcome
Transition states were identiﬁed through an initial potential energy surface scan and further
optimized. The corresponding product or starting material structures were obtained through
dynamic reaction coordinate calculations. After having identiﬁed the rate- and selectivity-
determining steps, the corresponding transition states 69 and 64 were studied in detail to
establish a structure-selectivity relationship. The main focus of the transition state analysis
was to investigate the eﬀect of the t-Bu groups in the DTB-SDP ligand. One distinctive
diﬀerence between 69 and 64 is the orientation of the substrate in reference to the ligand
(Figure 3.5). In transition state 69a, the bound substrate (Figure 3.5, highlighted in green)
leans more towards the left side of the ligand and has a closer contact with one of the aryl
groups. This results in a CH–pi interaction (2.37 A˚) between the aryl group and one of the
methylenes in the substrate (Figure 3.5).195–202
In transition state 64a, coordination of the other face of the oleﬁn, results in situating the
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Figure 3.5. Analysis of the transition state geometries
substrate away from the ligand, compared to 69a. The previously observed CH–pi interaction
is weakened in 64a (2.74 A˚). In light of these observations, a simple explanation for the
experimentally observed selectivities would be the destabilization of transition state 69b.
Steric repulsion between the t-Bu groups on the DTB-SDP ligand and the substrate would
interrupt any attractive interactions. However, this hypothesis could not be tested. The
CH–pi interaction (2.37 A˚) is still present in 69b. Comparing the transition state structures
obtained with Ph-SDP and DTB-SDP showed, that there was little to no inﬂuence on the
transition state geometry of the substrates (RMSD <0.02 A˚). There is also little change
in the conformations of the Ph-SDP ligand in 69a and 64a, which can be seen in the
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superimposition of both ligands (Figure 3.5, top right, RMSD = 0.1 A˚). Going to the DTB-
SDP ligand, a change in conformation is apparent when superimposing both structures
(Figure 3.5, bottom right, RMSD = 0.6 A˚). Most notably, the 3,5-di-tert-butyl benzene ring
to the right of the substrate rotates inwards in 69b (Figure 3.5, bottom). This brings one
of the t-Bu groups closer to the substrate, whereas in 64b the 3,5-di-tert-butyl benzene ring
rotates outwards to accommodate the diﬀerently situated substrate, moving one of the t-Bu
away from the substrate.
These diﬀerent ligand conformations have inherently diﬀerent stabilities. The experimen-
tally observed selectivities can therefore be dictated by the stabilities of the diﬀerent ligand
conformations.
∆E‡ = ∆Eint +∆Edist (3.1)
∆Eint = ∆Eint,ligand +∆Eint,substr +∆Eint,space/bond (3.2)
∆Edist = ∆Edist,ligand +∆Edist,substr (3.3)
To ﬁnd further support for this qualitative analysis, the transition states were fragmented into
the ligand portion and the substrate portion (containing the Rh metal), and studied using
the distortion/interaction-activation strain model.203–209 In this model, ∆E‡ is described as
the sum of the interaction energy (∆Eint) and the distortion energy (∆Edist) (Eq. 3.1).
∆Eint describes all the interactions within the ligand and substrate fragment, as well as
the interaction between those two fragments. While the distortion energy is related to the
change in energy, when distorting the geometry of a fragment going towards the transition
state structure. This data can be further deconvoluted by describing ∆Eint through the
sum of the interaction energy within the ligand (∆Eint,ligand), the interaction energy within
the substrate (∆Eint,substr) and the interaction energy between the substrate and the ligand
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(∆Eint,space/bond) (Eq. 3.2). In a similiar way, ∆Edist can be seen as the sum between
the distortion energy within the ligand (∆Edist,ligand), and the distortion energy within the
substrate (∆Edist,substr) (Eq. 3.3).
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Figure 3.6. Distortion-interaction energies
The results from the distortion/interaction-activation strain model are shown in Figure 3.6.
In the case of Ph-SDP (red bars), ∆Eint is slightly in favor for the Heck-type pathway, while
∆Edist is almost identical for both pathways. Going to the DTB-SDP cases (blue bars),
∆Eint is now more favorable for the carboacylation pathway. It is also apparent from the
change of ∆Eint,space/bond, when going from Ph-SDP to DTB-SDP, that the experimentally
observed selectivities cannot be explained through a change in the interaction between the
ligand and the substrate. On the other hand, ∆Edist increases to a greater extent for the
carboacylation pathway, than for the Heck-type pathway. To further deconvolute, the same
model has been applied to the substrate fragment and the ligand fragment.
The distortion/interaction-activation strain model unveils signiﬁcant changes in the ligand
fragment when going from Ph-SDP to DTB-SDP (Figure 3.7, right side). While the Ph-SDP
ligand in the carboacylation pathway adopts a more favorable conformation in the transition
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Substrate Fragment Ligand Fragment
Figure 3.7. Distortion-interaction energies for ligand and substrate fragments
state, the DTB-SDP ligand adopts a less favorable conformation (∆Eligand = -0.65 kcal/mol
and 0.61 kcal/mol, respectively). This diﬀerence stems mainly from ∆Eligand,int, showing that
the conformational change in DTB-SDP from the ground state to the transition state aﬀects
the weak-interaction network within the ligand. Futhermore, ∆Eligand,dist also increases in
the case of DTB-SDP. For the Heck-type pathway, ∆E‡ligand, ∆Eligand,int, and ∆Eligand,dist do
not diﬀer signiﬁcantly, when comparing Ph-SDP and DTB-SDP. Same is also true for the
substrate fragment. In the carboacylation pathway ∆E‡substr is higher for DTB-SDP than
for Ph-SDP which stems from a higher ∆Esubstr,dist. The diﬀerence in ∆E
‡
substr is not as
pronounced as the diﬀerence in ∆E‡ligand. While both, the change in ∆E
‡
substr and ∆E
‡
ligand
contribute to the experimentally observed selectivities, the changes within the ligand weights
proportionally stronger.
3.1.3 Conclusion and Future Work
Adding the t-Bu groups in DTB-SDP enhances the ligands ability to “sense” the substrate
(through weak interactions), resulting in a conformational adaptation of the ligand in accor-
dance to the bound substrate. The conformational change in the ligand is more pronounced
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and aﬀects the ligand’s weak-interaction network, proportionally. This mode of action allows
us to diﬀerentiate two very similar transition states and selectively favor one over the other.
Ligand
Ligand
Sub
M
Ligand
Sub
Sub
M
common intermediate M
carboacyaltion
Heck-type
ligand stability controls selectivity
Figure 3.8. Distortion-interaction energies for ligand and substrate fragments
Rather than operating under the common lock and key model in transition metal catalysis,
this study unveils an induced-ﬁt-type mechanism. In analogy to the induced-ﬁt mechanism
in enzymes, the substrate in this study induces a conformational change in the ligand, which
then leads to the selective promotion of one pathway.
After having gained a deep inside into the structure-selectivity relationship, future work
focuses on the in-silico design of new ligands and catalysts, to selectively enable the carboa-
cylation pathway over the Heck-type pathway.
3.2 In-Silico Catalyst Design and Synthesis of a New
Class of Ligand
3.2.1 Introduction
Based on the ﬁndings from the previous DFT studies, the next goal was to design new
catalysts and ligands in silico to enable the selective synthesis of 21, over 22. Our previous
experimental attempts to ﬁnd a selective catalyst system were unfruitful.
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With the insight into the rate-determining step and the transition state geometries in hand,
the focus was now on the in-silico design of SDP-type ligands. The main diﬀerence between
transition states 69a and 64a is the diﬀerent spatial relationship between the substrate and
the ligand.
2.34 Å 3.90 Å
69a 64a
Figure 3.10. CH-pi interaction between ligand and substrate
This results in a diﬀerentiation of the two transition states through their weak interactions
between ligand and substrate (∆Eint,space/bond). Most notabe is the CH–pi bond in 69a
with an interaction distance of 2.34 A˚, while in 64a this distance is 3.90 A˚, for the same
methylene (Figure 3.10). Increasing the CH–pi interaction could stabilize 69a over 64a.
Dispersive as well as electrostatic interactions are the main contributors to CH–pi bonds.
Changing the electronic properties of the aromatic ring can modulate the strength of the
CH–pi bond.197,198,210 We hypothesized that increasing the negative charge on the aromatic
ring would strengthen the electrostatic interaction with the positively charged H-atom.211,212
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3.2.2 Results and Discussion
All in-silico designed ligands are based on the SDP backbone 72.213–215 The aromatic rings
that are attached to the phosphines were modulated. To tune the electronic properties, diﬀer-
ent para-substituted benzenes as well as heterocycles have been investigated (Figure 3.11).211
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Figure 3.11. Predicted rr of in-silico designed SDP-variants
Changing the substituent in the para position with electron donating groups (i.e. 72h, 72i,
72j, 72k, 72l) had little eﬀect and changed the regioselectivity from 1:2 to 2:1. Interestingly,
when using ligand 72m with the electron deﬁcient perﬂouro benzenes, the Heck-type path-
way becomes more favorable. Inversion of the quadrupole moment of the benzene leads to
electrostatic repulsion with the H-atom involved in the CH–pi bond, eﬀectively destabilizing
transition state 69m. Overall, the eﬀects on the selectivity when modulating the benzene
motif are marginal. Employing heterocycles had a greater eﬀect on the selectivity. Ligand
72d, containing the electron-rich N -methylpyrrole, increased the predicted regioselectivity
to 17:1, by strengthening the CH–pi (2.27 A˚). In a similiar way, imidazole containing ligand
72e switches the regioselectivity towards 21a with 66:1 rr. In this case, there is a further
stabilization of transition state 69e, through coordination of the imidazole nitrogen to Rh.
Although also electron rich, indole did not aﬀect the regioselectivity. On the other hand,
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when employing electron deﬁcient heterocycles like thiophene (72f) and furan (72g), the se-
lectivity switches, and favors 22a (1:10 and 1:10 rr, respectively). While modulation of the
electrostatic properties had only minor success, increasing the dispersive interactions could
have a greater inﬂuence on the selectivity. We tested diﬀerent substituents in the ortho and
meta position of the benzene rings. Substitution at the ortho position of the benzenes (72n)
is not tolerated and leads to decoordination of the ligand in-silico, which is in agreement
with previous experimental studies.216 Interestingly, when using ligand 72o, bearing bicy-
clo[1.1.1]pentane substituted benzenes, 21a is now favored with 14:1 rr. This is presumably
a result of increased dispersive interactions. Employing substituents with a bigger surface
area, to further increase the weak-interactions, was unsuccessful. The adamantyl group in
72p was too bulky to be attached to the ligand.
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Figure 3.12. Proposed ligand design
Substitution at the ortho position of the blue benzene ring in 69 (Figure 3.12) introduces too
much steric interaction, while substituents in the meta position can have some constructive
interactions with the substrate, but the substitutents point partly away from the substrate.
The ideal substituent would be between (metaxy) the ortho and the meta position. A metaxy
substituent would decrease steric repulsion with the metal and at the same time increase
the surface area that is in contact with the substrate. Formally, a metaxy substitution could
be realized through a 3-center 2-electron (3c-2e) bond. While there are a few examples
of 3c-2e bonds in hydrocarbons (i.e. ethanium and ethenium),217–221 they are generally
rare and highly reactive species. Motifs that are isosteric to metaxy sustituents can be
realized, though. Rings that are fused at the ortho and meta positions, and with ring
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sizes of cyclopentane or smaller, can be seen as isosteres to metaxy substituents due to the
compression of the bonding angles.
MeMe
""
110.8° 93.8° 63.1°
R R Rmetaxy substituted
metaxy isosteres
" "
Figure 3.13. Isosteric relationship between ortho,meta and metaxy substitution
Based on this idea, a series of diﬀerent ligands have been in investigated in-silico, bear-
ing either ortho and meta or metaxy-isosteric substitution (Table 3.2). Ligand 72s, with
cyclohexane rings fused to the benzene rings, shows no improvement in the predicted re-
gioselectivity, which is most likely a result of unfavorable steric interactions. Naphthalene
substituted ligand 72t improves the regioselectivity and favors 21a by 38:1 rr. Naphthalene
and other extended aromatic systems have been used before in catalysis as dispersion energy
donors.222–226 Going to the metaxy isosteric substituents, ligand 72u with cyclopropyl-fused
benzene rings also starts to favor 21a with 12:1 rr. Interestingly, the introduction of only
two methylenes per benzene ring already introduced enough dispersive interactions to favor
the carboacylation product 21a. The cyclobutyl- and cyclopentyl-fused ligand variants 72v
and 72w show even higher dispersive interactions, with 123:1 rr and 119:1 rr, respectively.
With these in-silico designs in hand, I attempted to synthesize the most promising ligand.
Previous attempts in synthesizing cyclopropyl-fused benzene rings like in ligand 72u were not
successful, making this designed ligand combined with the predicted 12:1 rr an unappealing
target for synthesis.227–229 The homologous cyclobutyl-fused benzene ring is known in the
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Table 3.2. Predicted rr for ligands with metaxy-isosteric benzenes
38:11:2
ortho & meta substitution
Ar =
12:1 123:1 119:1
metaxy-isosteric substitution
P P
Ar Ar Ar
Ar
Ar =
72
72s 72t 72u 72v 72w
literature but the precursor synthesis can involve many steps.230–235 All attention has been
focused on ligand 72w, where the corresponding hydrindacene can be build up through a
series of Friedel-Crafts acylation and alkylation (Figure 3.14).236
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Figure 3.14. Synthesis of bromo-hydrindacene 78
Starting from indane (74) and 3-chloropropionic acid chloride (73) indane 75 was aﬀorded in
85% yield after Friedel-Crafts acylation. In neat H2SO4, the pending alkyl chloride and the
indane motif undergo a Friedel-Crafts alkylation, aﬀording a mixture of s-hydroindacenone
76a and as-hyrdoindacenone 76b in 6:1 rr. Although inseparable by column chromatog-
raphy, the minor regioisomer was removed through recrystallization. Hydrogenation with
palladium on carbon reduced s-hydroindacenone 76a to hydrindacene 77 in 91%. In the
last step, a mild mono-bromination protocol was applied to give bromohydrindacene 78 in
near quantitative yield.237
With bromohydrindacene 78 in hand, the corresponding Grignard reagent was formed and
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Figure 3.15. Attempted coupling of phosphine oxide 79 to SDP backbone
added to diethyl phosphite to give phosphine oxide 79 in 19% yield (Figure 3.15). The next
key step was the cross-coupling of phosphine oxide 79 to (R)-spinol-OTf. Under all the
tested palladium cross-coupling conditions no product formation was ever observed. This
might be due to the steric hindrance of phosphine oxide 79.214,215
69w 69z69z
Figure 3.16. Dispersion interaction density plot with 72w and 72z
Going back to transition state 69w, the key contacts between ligand and substrate have
been visualized in a dispersion interaction density plot (Figure 3.16). Only two out of the
four s-hydrindacenes of the ligand are in contact with the substrate. In the next iteration of
in-silico designs, the new ligands bear now asymmetric phosphines. Where one aryl group
carries a metaxy isosteric substitution and the other remains as phenyl group (Table 3.3).
Table 3.3. Predicted rr for P-chiral ligand designs
10:1 1.797:1 9.083:1
"metaxy" substitution
P P
Ar
Ph
Ar
Ph
Ar =
72
72x 72y 72z
The predicted rr did not change signiﬁcantly for ligand 72x, bearing the cyclopropyl-fused
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benzenes. Surprisingly, the rr changed dramatically for ligand 72y and 72z with 1.797:1
and 9.083:1 rr, respectively. To better understand the surge in rr, ligand 72w (ω-SDP,
four s-hydrindacenes) and 72z (ω∗-SDP, two s-hydrindacenes) have been studied, using the
distortion/interaction-activation strain model (Figure 3.17).203–209
Figure 3.17. Distortion-Interaction analysis for new SDP-ligands
Overall, ∆E‡ is reduced by around 2 kcal/mol for the carboacylation pathway, when going
from ω-SDP to ω∗-SDP. While ∆E‡ remains similar for the Heck-type pathway. Going into
more detail, ∆Eint gets weaker for both pathways by a similar magnitude when comparing
ω-SDP to ω∗-SDP. This trend is also observed for ∆Eint,space/bond, which is part of ∆Eint (Eq.
3.2). As a side note, ∆Eint,space/bond increased signiﬁcantly, in both ω-SDP and ω
∗-SDP when
compared to Ph-SDP and DTB-SDP. The surge in rr for ω∗-SDP stems from ∆Edist which
decreases by around 6 kcal/mol for the carboacylation pathway, compared to a decrease of
3 kcal/mol for the Heck-type pathway. Looking at the individual contributors (Eq. 3.3),
∆Edist,ligand decreases for both pathways. The increase in the predicted selectivity stems
from ∆Edist,substr, which decreases for the carboacylation pathway by around 3 kcal/mol,
while staying similar for the Heck-type pathway. The greater conformational freedom within
in the ligand allows for a lower ∆Edist,substr.
After synthesizing (R)-80, the key cross-coupling was tested again. With the less bulky
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Figure 3.18. Coupling of 80 to the SDP backbone
phosphine oxide (R)-80, the desired coupling product was obtained in about 40% yield.
3.2.3 Conclusion and Future Work
In summary, several new ligands have been designed in silico, with promising predicted
selectivities. The insights gained from the computations allowed us to establish a structure-
selectivity relationship, resulting in the design of new dispersion energy donors, that ﬁt the
unique requirements of transition metal catalysis. Current experimental eﬀorts are guided
by the computational results and future work will involve the case studies of other transfor-
mations.
3.3 Experimental and Computational Data
3.3.1 Computational Details
Orca 3.0.3 was used to optimize the relaxed potential energy surfaces (PES) using “Grid4”
and “TightSCF” as settings.238 Turbomole 7.0 with grid m4 239 was used in other compu-
tations. The TPSS240 functional and def2-SVP or def2-TZVP basis sets241 were used to
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compute single point energies and to optimize structures. Additionally, the BJ-damped
D3-dispersion correction (-D3)242,243 was used, as well as resolution-of the-identity approxi-
mation for Coulomb term (RI-J)244 or multipole-accelerated RI-J (MARI-J).245 In the later
cases, the corresponding auxiliary basis set246 was used. Structures were illustrated using
Cylview∗.
TPPS was chosen over other functionals due to its reliable performance with a variety of
diﬀerent elements, including transition metals.†
TPSS-D3/def2-TZVP was used to compute the numerical harmonic vibrational frequencies
for all studied transition states (TS). The standard rigid-rotor harmonic-oscillator approx-
imation was used to calculate the chemical potential (c.p.) which was used to study the
Gibbs free energies (G = E(0) + c.p.).
It was found experimentally that non-polar solvents with diﬀerent dielectric constants do
not inﬂuence the reaction. All calculations were therefore performed in vacuo.
Protocol for Transition State Identification
The PES of a reaction step was modeled through ORCA by using 0.1 A˚ ingrements. The
obtained transition state structure was then optimized in Turbomole.
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Protocol for Distortion/Interaction-activation strain model
A similar protocol to a previously reported unimolecular reaction has been applied.249–251
The distortion energies for the substrate portion and the ligand portion were determined by
fragmenting at the indicated position in Figure 3.19. The ends of the fragments were capped
with hydrogen atoms.
P P
O
Me
Rh
R
Substrate Fragmentation Ligand Fragmentation
Figure 3.19. Fragmentation of substrate and ligand fragment
∗CYLview, 1.0b, C.Y., Legault. Universite´ de Sherbrooke, 2009.
†Goerigk, L.; Grimme, S. Phys. Chem. Chem. Phys. 2011, 13, 6670–6688.
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Coordinates
All coordinates can be found in the digitally appended text ﬁle.
3.3.2 Experimental Details
Commercial reagents were purchased from Strem, Sigma Aldrich, Alfa Aesar, Acros, Combi-
Blocks and Chem-Impex and used without further puriﬁcation. All reactions were carried
out under an atmosphere of nitrogen unless otherwise indicated. Solvents used in cobalt-
catalyzed reactions were ﬁrst distilled and then degassed by three freeze-pump-thaw cycles
before being taken into a glove box. Other solvents were dried through two column of
activated alumina. Reactions were monitored using GC/MS, GC/FID or thin-layer chro-
matography (TLC) on EMD Silica Gel 60 F254. Visualization of the developed plates was
performed under UV light (254 nm), KMnO4, cerium molybdate, and phosphomolybdic acid
stain. Column chromatography was performed with Silicycle Silia-P Flash Silica Gel using
glass columns. Organic solutions were concentrated under reduced pressure on a Bu¨chi ro-
tary evaporator. 1H and 13C NMR spectra were recorded on a DRX 400, GN 500, CRYO
500, or CRYO 600 spectrometer. NMR spectra were internally referenced to the residual
solvent signal. Data for 1H NMR are reported as follows: chemical shift (δ ppm), multiplicity
(s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, br = broad), coupling
constant (Hz), integration. Data for 13C NMR are reported in chemical shift (δ ppm). High
resolution mass spectra (HRMS) were obtained on a micromass 70S-250 spectrometer (EI)
or an ABI/Sciex QStar Mass Spectrometer (ESI). Infrared (IR) spectra were obtained on a
Perkin-Elmer Spectrum 1000 FT-IR Systems and are reported in terms of frequency of ab-
sorption (cm−1). Enantiomeric excess (ee) was ascertained on an Agilent 1100 Series HPLC
or Agilent 1200 Series/Aurora SFC. Optical rotations were measured on a Rudolph Research
Analytical Autopol IV Automatic Polarimeter.
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3-chloro-1-(2,3-dihydro-1H-inden-5-yl)propan-1-one 75
O
Cl
In a 500 ml schlenk ﬂask was added aluminum trichloride (27.0 g,
0.20 mol) in DCM (142 ml) to give a yellow suspension. 3-
Chloropropionyl chloride (17.7 ml, 0.18 mol) was added dropwise over
30 minutes. Afterwards, indan (22.6 ml, 0.18 mol) was added dropwise.
The yellow suspension turned into a dark red solution. The reaction
mixture was quenched after 1 hour with 1 M HCl (100 ml) solution. The aqueous layer was
extracted with DCM (50 ml) four times. The organic layers were washed with sat. NaCl (aq)
(100 ml) combined, and dried over MgSO4,ﬁltered, and concentrated. The unpuriﬁed reac-
tion mixture was then puriﬁed by recrystallization from hexanes, to aﬀord 32.7 g of (75) as a
crystalline solid, 85% yield.
1
H-NMR: δ (600 MHz, CDCl3) 7.82 (s, 1H), 7.75 (d, J = 7.8 Hz,
1H), 7.31 (d, J = 7.8 Hz, 1H), 3.92 (t, J = 6.7 Hz, 2H), 3.44 (t, J = 6.7 Hz, 2H), 2.96 (t, J
= 7.3 Hz, 4H), 2.12 (p, J = 8.1, 7.6 Hz, 2H).
13
C-NMR: δ (151 MHz, CDCl3) 196.83, 150.98,
145.13, 135.07, 126.74, 124.63, 124.12, 41.48, 39.12, 33.20, 32.70, 25.50. HRMS (ESI-TOF)
m/z calc’d for C12H13ClO [M+Na]
+: 231.0553, found 231.0547. IR (ATR): 2953, 1674, 1603,
1415, 1349, 1274, 1219, 1142, 996, 914, 825, 777, 690, 618 cm−1.
3,5,6,7-tetrahydro-s-indacen-1(2H )-one 76a
O
In a 125 ml round-bottom ﬂask was added sulfuric acid (97 ml, 1.83
mol). Indan 75 (25.4 g, 0.12 mol) was added in 3 g portions. The
colorless solution turned dark red and was heated at 70 ◦C. The reaction
mixture was quenched after 3 hours by pouring the reaction mixture
into ice water. The aqueous layer was extracted with DCM (25 ml) three times. The organic
layers were washed with sat. NaCl (aq) (50 ml) combined, and dried over MgSO4,ﬁltered, and
concentrated. The unpuriﬁed reaction mixture was then puriﬁed by recrystallization from
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hexanes with a minimal amount of ethyl acetate, to aﬀord 9.5 g of (76a) as a crystalline solid,
45% yield.
1
H-NMR: δ (499 MHz, CDCl3) 7.57 (s, 1H), 7.29 (s, 1H), 3.15 – 3.02 (m, 2H),
2.93 (dt, J = 14.6, 7.4 Hz, 4H), 2.77 – 2.62 (m, 2H), 2.12 (p, J = 7.5 Hz, 2H).
13
C-NMR:
δ (151 MHz, CDCl3) 206.86, 154.55, 153.10, 144.29, 136.08, 122.30, 119.10, 36.93, 33.23,
32.18, 25.98, 25.68. HRMS (ESI-TOF) m/z calculated for C12H12O [M+Na]
+: 195.0786,
found 195.0794. IR (ATR): 2954, 2920, 1691, 1614, 1433, 1300, 1270, 1249, 1149, 1085, 986,
876, 862, 821, 612 cm−1.
1,2,3,5,6,7-hexahydro-s-indacene 77
In a 300 ml beaker was ketone 76a (2.7 g, 15.62 mmol), and palladium
on carbon (3.3 g, 5 wt%, 1.56 mmol). Ethanol (156 ml) was carefully
added under a stream of nitrogen. The beaker was placed into a 600 ml
a series 4760 parr reactor and pressurized with hydrogen gas to 200 psi.
After 24 hours, the pressure was released, and the palladium catalyst removed by ﬁltration
through a pad of silica. The crude reaction product was eluted with diethyl ether. The
unpuriﬁed reaction mixture was concentrated, to aﬀord 2.2 g of (77) as a crystalline solid,
91% yield.
1
H-NMR: δ (500 MHz, CDCl3) 7.10 (s, 2H), 2.87 (t, J = 7.4 Hz, 8H), 2.08 (p, J =
7.4 Hz, 4H).
13
C-NMR: δ (126 MHz, CDCl3) 142.35, 120.43, 32.68, 26.12. HRMS (ESI-TOF)
m/z calculated for C12H14 [M]
+: 158.1095, found 158.1091. IR (ATR): 2935, 2841, 1481,
1439, 1319, 1254, 1211, 1037, 863 cm−1.
4-bromo-1,2,3,5,6,7-hexahydro-s-indacene 78
Br
In a 100 ml schlenk ﬂask was hydroindacene 77 (2.0 g, 12.64 mmol) in
MeCN (25.3 ml) to give colorless solution. The reaction was cooled to
0 ◦ and the reaction ﬂask wrapped in aluminum foil, to avoid external
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light. N -bromosuccinimide (2.5 g, 13.90 mmol) was added and the
reaction stirred at 0 ◦. The reaction mixture was quenched after 3 hours by pouring the
reaction into a 250 ml erlenmeyer ﬂask, ﬁlled with 2.5 M NaOH solution (100 ml). The
aqueous layer was extracted with ethyl acetate (20 ml) three times. The organic layers were
washed with 2.5 M NaOH solution (50 ml), sat. NaCl (aq) (50 ml) combined and dried over
MgSO4,ﬁltered, and concentrated. The unpuriﬁed reaction mixture was used in the next
reaction without further puriﬁcation.
bis(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)phosphine oxide 79
O
P
H
In a 25 ml schlenk tube was added magnesium (170 mg, 6.95 mmol) in
THF (1 ml) to colorless suspension. A few grains of Iodine were added.
Bromohydroindacene 78 (0.5 ml, 12 M in THF, 5.90 mmol) was added
dropwise. The reaction mixture was stirred at room temperature for 1
hour, then heated to 40 ◦ for 30 minutes. Diethylphosphite (0.45 ml,
3.47 mmol) was added and the reaction heated to 60 ◦ for 2 hours and then stirred at room
temperature. The reaction mixture was quenched after 24 hours with 1 M HCl solution
(2 ml). The aqueous layer was extracted with diethyl ether (5 ml) three times. The organic
layers were washed with 1 M HCl solution (5 ml), sat. NaCl (aq) (5 ml) combined and dried
over MgSO4,ﬁltered, and concentrated. The unpuriﬁed reaction mixture was then puriﬁed
by column chromatography (50% Ethyl acetate in Hexanes), to aﬀord 245 mg of (79) as a
crystalline solid, 19% yield.
1
H-NMR: δ (500 MHz, CDCl3) 8.32 (d, J = 470.6 Hz, 1H), 7.24
(s, 2H), 2.99 – 2.76 (m, 16H), 2.04 (p, J = 7.2 Hz, 8H).
13
C-NMR: δ (126 MHz, CDCl3)
145.28 (d, J = 10.2 Hz), 143.79 (d, J = 10.1 Hz), 124.45 (d, J = 2.8 Hz), 31.64 (d, J
= 4.6 Hz). HRMS (ESI-TOF) m/z calculated for C24H27OP [M+Na]
+: 385.1697, found
385.1698.
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Chapter 4
Copper Catalyzed Synthesis of
γ, δ-Unsaturated Nitriles∗
∗Reproduced in part with permission from Wu, X.; Riedel, J.; Dong, V. M. Angew. Chem. Int. Ed.
2017, 56, 11589. Copyright 2017 Wiley
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4.1 Introduction
Although radicals play a key role in biochemistry,252–255 their potential for use in organic syn-
thesis is vast, with new concepts continually emerging,256–266 including applications in cross-
coupling.267–275 By combining Cu catalysis with radicals, Heck-type transformations have
been achieved, including allylic triﬂuoromethylation,276–280 arylation,281 and alkylation.282–287
These radical transformations enable bond construction patterns that were previously im-
possible, and provide an attractive approach for oleﬁn synthesis (Figure 4.1). Inspired by
the versatility of nitriles,288–290 we designed a strategy for transforming simple oleﬁns into
γ,δ-unsaturated nitriles by taming the reactivity of the cyanoalkyl radical. Rather than re-
quiring functionalized halides and toxic cyanide reagents, this transformation enables oleﬁn
feedstocks to be coupled with alkyl nitriles to generate homoallylic nitriles in a single step,
using an earth-abundant metal catalyst (Figure 4.1).291,292
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Figure 4.1. Allylic cyanoalkylation
The nitrile functional group is common in both materials293 and medicines,294,295 and is
also a useful handle for elaboration.288–290 As shown in Figure 4.1, we proposed a cross-
dehydrogenative coupling (CDC)296–301 between an oleﬁn and acetonitrile.302,303 Initial ox-
idation of an alkylnitrile forms the corresponding cyanoalkyl radical, which can add to an
oleﬁn to give the alkyl radical 82.304–316 Radicals such as 82 have been implicated in oleﬁn
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hydrocyanoalkylations304–307 and bifunctionalizations.308–316 In the presence of a copper(II)
catalyst, Koichi showed that radicals can be trapped to generate the alkylcopper(III) inter-
mediate 83 with rate constants in excess of 106M−1s−1.317–321 Theoretical studies on the CF3
allylic functionalization invoke a triﬂate-counterion-assisted elimination.278 On the basis of
these studies, we reasoned that the appropriate counterion would be critical for controlling
regio- and stereochemistry in the ﬁnal elimination.322,323
With this mechanistic hypothesis in mind, we focused on the Cu-catalyzed allylic cyanoalky-
lation of 1-dodecene in acetonitrile, using di-tert-butyl peroxide (DTBP) as the oxidant.
DTBP is a convenient and inexpensive radical initiator in synthetic and polymer chem-
istry, and is commonly used for generating radicals from acetonitrile.304–316 Zhu and co-
workers demonstrated that Cu/peroxide can generate cyanoalkyl radicals from alkylnitriles,
which can then add to alkenes through an intermolecular process.308–310,314,315 In Zhu’s work,
the generated alkyl radicals are typically trapped to aﬀord bifunctionalizations, such as
oxycyanoalkylations309,310,314,315 and arylcyanoalkylation.308 Rather than addition reactions
across the oleﬁn, we envisaged diverting 82 to achieve dehydrogenative oleﬁn functionaliza-
tion.
4.2 Results and Discussion
In the absence of copper, treatment of 1-dodecene with DTBP aﬀorded the known hydro-
cyanoalkylation product 90a in 25% yield, with no desired cyanoalkene 89a. Copper(I) and
copper(II) complexes bearing weak counterions provided 90a as the major product (28–70%
yields; Table 4.1), in accordance with reported studies on hydrocyanoalkylation.304–307 The
catalysts used by Zhu and co-workers were not eﬀective in our proposed allylic cyanoalkyla-
tion.308–310,314,315 In contrast, (thiophene- 2-carbonyloxy)copper(I) (CuTc, previously used as
a catalyst in allylic triﬂuoromethylation278) provided cyanoalkene 89a as the major product
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in 30% yield. In comparison to copper(I) acetate, we found that copper(II) acetate showed
higher eﬃciency and chemoselectivity, providing 89a in 47% yield with >20:1 regioselectiv-
ity. By replacing acetate with the more basic pivalate, the desired alkene was obtained in
65% yield, >20:1 regioselectivity. Other oxidants such as tertbutyl hydroperoxide (TBHP)
and dicumyl peroxide (DCP) were ineﬀective. Using an electron-rich benzonitrile derivative
as an additive further improved eﬃciency, presumably by improving catalyst solubility. In
the presence of one equivalent of veratronitrile, 89a was obtained in 90% yield, greater than
20:1 rr, and 4:1 E/Z. Only trace amounts of 90a were observed (<5% yield). These results
support the notion that a carboxylate counterion facilitates the elimination and enables
>20:1 regioselectivity to provide the γ,δ-unsaturated nitrile. A syn elimination aﬀords the
E isomer as the major product.[19]
Table 4.1. Counter effects on Cu-catalyzed allylic cyanoalkylation
CNH+
H
Me
8
cat. CuXn
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MeCN, 110 °C
Me CN
H
8
Me CN8
+
O Ot-Bu t-Bu
DTBP
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CuOTf[c] CuI CuTc CuOAc
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0%
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0%
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30%
10%
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<5%
65%
<5%
90%(86%)[d]
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Cu(II)
87a 88a 89a
90a
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With this method, we elaborated a wide range of terminal oleﬁns (Table 4.1). Unactivated
linear terminal oleﬁns gave the corresponding γ,δ-unsaturated nitriles (89a–c) in 80–86%
yields with >20:1 rr and 4:1 E/Z. For the substrates bearing ester (89d, 89e), amide (89f),
cyano (89g), and ether (89h) groups, regioselective CDC reactions with acetonitrile pro-
vided the corresponding products in 75–82% yields. Increasing the steric hindrance at the
4-position of the oleﬁns slightly decreased the yields but increased the E/Z ratios of the prod-
ucts (89i 7:1 E/Z ; 89j 11:1 E/Z ; 89k >20:1 E/Z ). With a tertbutyl group at the 3-position,
we observed >20:1 regioselectivity and >20:1 E/Z selectivity (89k). The regioselectivity was
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unaﬀected by increased steric hindrance at the 4-position of the oleﬁns. 3-Aryl-substituted
substrates gave the corresponding nitriles (89l–n) in 40–46% yields with >20:1 E/Z selec-
tivity. A substrate with an electron-withdrawing group on the phenyl ring (89n) showed
slightly higher reactivity than one with an electron-donating group (89m). Trisubstituted
alkenyl nitriles were synthesized in 50–77% yields from 3,3- and 1,1-disubstituted oleﬁns
(89o–r and 89t). A series of nitriles were also tested as coupling partners. Propionitrile and
butyronitrile showed decreased reactivity compared to acetonitrile, most likely due to steric
eﬀects and the lower solubility of the copper catalyst in these nitriles (89w, 89x). Trans-
formation with styrene, which has no allylic C–H bond, gave β,γ-unsaturated nitrile 89y in
10% yield. Only trace amounts of the hydrocyanoalkylation product 90 were observed with
the oleﬁns shown in Figure 4.2. Having established facile access to various nitriles, we next
focused on applying them as building blocks.
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Figure 4.2. Allylic cyanoalkylation of terminal oleﬁns
Owing to the versatility of the cyano group, we were able to use simple oleﬁns to access
a range of valuable products, including an industrial ﬂavor agent, a natural product, and
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a polymer precursor (Figure 4.3). For example, treatment of 89b with TMSCl in ethanol
provided the pear ﬂavoring ethyl 4-decenoate (91) in 85% yield.324 The 4-alkyl γ-lactones are
members of a large family of natural ﬂavors that are widely used in food industry.325,326 From
the same compound 89b, γ-decalactone (6) was obtained in 73% yield through a one-pot,
hydrolysis and intramolecular hydroacyloxylation. Our strategy provides an eﬃcient route
to fatty acids. For example, lyngbic acid, which is isolated from the marine cyanophyte
Lyngbya majuscule,327 exhibits antimicrobial activity.328 Through hydrolysis of the cyano
group in compound 89h, lyngbic acid (93) can be obtained in 87% yield. Ru-catalyzed
hydrogenation of 89d provided the nylon-9 precursor 94 in 75% yield.329
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Figure 4.3. Application of the γ,δ-unsaturated nitriles
Next, we examined internal oleﬁns (Figure 4.4). With (E )-5-decene, the transformation gave
cyanoalkene 89y in 62% yield with >20:1 rr and 11:1 E/Z after 24 h (Figure 4.4a). With
(Z )-5-decene, the E isomer 89y was obtained as the major product in a similar yield and
E/Z selectivity as the E -oleﬁn substrate (60% yield, 12:1 E/Z ) (Figure 4.4b). The C–C
bonds were formed at the 5-position of the substrates. No 3- propylnon-4-enenitrile (97) was
observed from either the potential allylic radical 95 or pi-allylcopper intermediate 96 through
allylic C–H bond activation (Figure 4.4c). We observed no carbocation-rearrangement-type
products (100), which would arise from the carbocation intermediate 98 (Figure 4.4d).330
Nor were these 1,2-hydride shift products detected in experiments yielding compounds 89o–q
(Figure 4.2). These observations suggest that allylic radicals or carbocations are most likely
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not key intermediates in our cross-coupling.
On the basis of further experiments and previous reports,307–311,313–316 we propose the mech-
anism shown in Figure 4.5. Pivalate-assisted deprotonation of alkylnitrile with copper(II)
pivalate produces the cyanoalkylcopper(II) species 32 (pathway a). Homolytic cleavage of
32 gives the cyanoalkyl radical and copper(I) species. Addition of the cyanoalkyl radical to
the oleﬁn generates the radical intermediate 82. Concerted carboxylate elimination of 82
provides the γ,δ-unsaturated nitrile product and a copper(I) species. To explain the regiose-
lectivity, we propose that pi-bonding of the cyano group to copper(III)331,332 shields the H at
the β position to direct the pivalate to abstract the H at the δ position. The copper(I) species
decomposes DTBP through a single-electron-transfer redox reaction to regenerate copper(II)
and a methyl radical. The methyl radical could also abstract hydrogen from alkylnitrile to
produce the cyanoalkyl radical (pathway b).
Cu(OPiv)2 (20 mol%)
Veratronitrile (1 equiv.) 
DTBP (4 equiv.)
MeCN, 110 °C, 24 h
nPr
CN
nPr
CN
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Figure 4.4. Allylic cyanoalkylation of internal oleﬁns
The following radical-trapping and radical-clock experiments support the proposed mecha-
nism (Figure 4.6). Formation of the allylic cyanoalkylation product was suppressed in the
presence of TEMPO, a known radical inhibitor. Instead, the products of cyanomethyl radi-
cal trapping (101) and methyl trapping (102) were both observed in 14% and 27% yields,
respectively. These results support the notion that cyanomethyl radical and methyl radical
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intermediates are involved in the transformation. In the absence of Cu(OPiv)2, the prod-
ucts 101 and 102 were also observed (in 5% and 39% yields, respectively). However, in
the absence of DTBP, only 101 was observed (12% yield). These results support the idea
that pathways a and b are responsible for the activation of acetonitrile. Next, we found
that the compound 104 was obtained in 60%yield from (1-cyclopropylvinyl)benzene (103)
through sequential ring opening of cyclopropylmethyl radical intermediate and cyclization
(Figure 4.6b).[6e,13b, 18] This radical-clock experiment supports the generation of 82.
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Figure 4.5. Proposed mechanism and rationale for the regioselectivity
In summary, we have developed a copper-catalyzed crossdehydrogenative coupling of un-
activated oleﬁns with alkylnitriles through dual sp3 C–H bond cleavage. High chemo- and
regioselectivity for E2-type elimination is conferred by 1) the pivalate counterion and 2) the
directing eﬀect of cyano groups. By using a catalyst derived from earth-abundant salts,
we can access 4-alkenylnitriles from simple oleﬁns. Both terminal and internal oleﬁns can
be transformed into γ,δ-unsaturated nitriles, which are versatile synthetic building blocks.
These studies contribute to the emerging use of radicals for catalytic cross-coupling.
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Figure 4.6. Intermediate-trapping and radical-clock experiment
4.3 Experimental Data
The details of the studies described in this chapter can be found in the Supporting Infor-
mation of the published manuscript.333 My contributions to the project are detailed in this
section.
4.3.1 Experimental Details
(1-cyclopropylvinyl)benzene 103
To a 100 ml schlenk ﬂask equipped with a stir bar was added methyl-
triphenylphosphonium bromide (9.1 g, 32.6 mmol) in THF (44 ml) to
give a white suspension. The reaction mixture was cooled to 0 ◦C and
n-BuLi (14.2 ml, 2.3 M, 32.6 mmol) was added dropwise to give a bright
red solution and was stirred for 1 hour at room temperature. Cyclopropyl(phenyl)methanone
(3.0 ml, 21.8 mmol) was added dropwise to give an orange solution. The reaction mixture
was heated to 65 ◦C and stirred for 24 hours. After complete conversion, the reaction was
diluted with pentane (40 ml) and aq. NH4Cl (30 ml) was added. The layers were separated
and the organic layer was washed with brine (30 ml) three times. The organic layer was
then dried over MgSO4 and concentrated under reduced pressure. Puriﬁcation of the crude
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residue by column chromatography (pentane) aﬀorded (1-cyclopropylvinyl)benzene (103) as
a colorless oil (2.0 g, 64% yield).
1
H-NMR: δ (400 MHz, CDCl3) 7.64 (dd, J = 8.3, 1.2 Hz,
2H), 7.41 – 7.35 (m, 2H), 7.34 – 7.29(m, 1H), 5.32 (s, 1H), 4.98 (s, 1H), 1.74 – 1.65(m, 1H),
0.90 – 0.84(m, 2H), 0.66 – 0.60 (m, 2H).
13
C-NMR: δ (101 MHz, CDCl3) 149.5, 141.8, 128.3,
127.6, 126.3, 109.1, 15.8, 6.8. This compound is known.334
3-(3,4-dihydronaphthalen-1-yl)propanenitrile 104
CN
In a N2-ﬁlled glovebox, veratronitrile (32.6 mg, 0.20 mmol) and dry ace-
tonitrile (1.5 ml) were added to a 1 dram vial (diameter 1.4 cm/height
4.3 cm) containing Cu(OPiv)2 (10.6 mg, 0.040 mmol). After stirring
for 3 minutes, 103 (29.0 mg, 0.20 mmol) and di-tert-butyl peroxide
(0.15 ml, 117 mg, 0.80 mmol) were added. The vial was sealed com-
pletely by a screw cap with a Teﬂon septum. Then the reaction mixture was stirred at 110 ◦C
for 6 hours. Upon completion, the reaction mixture was ﬁltered through a short silica gel
pad and washed with 50% ethyl acetate in hexanes. The ﬁltrate was concentrated in vacuo.
The selectivity was determined by NMR analysis of the unpuriﬁed reaction mixture. Pu-
riﬁcation of the crude residue by preparatory TLC (10% ethyl acetate in hexanes) aﬀorded
3-(3,4-dihydronaphthalen-1-yl)propanenitrile (104) as a colorless oil (22.0 mg, 60% yield).
1
H-NMR: δ (400 MHz, CDCl3) 7.25 – 7.12 (m, 4H), 6.01 (t, J = 4.6 Hz, 1H), 2.84 – 2.74 (m,
4H), 2.57 (t, J = 7.4 Hz, 2H), 2.33 – 2.27 (m, 2H).
13
C-NMR: δ (101 MHz, CDCl3) 137.0,
133.3, 133.2, 128.2, 127.6, 127.4, 126.7, 121.9, 119.5, 28.7, 28.2, 23.1, 16.9. This compound
is known.335
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D.1 NMR Spectra
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